EP2787065B1 - Detergent composition for textiles comprising rhamnolipids having a predominant share of di-rhamnolipids - Google Patents

Detergent composition for textiles comprising rhamnolipids having a predominant share of di-rhamnolipids Download PDF

Info

Publication number
EP2787065B1
EP2787065B1 EP14158279.1A EP14158279A EP2787065B1 EP 2787065 B1 EP2787065 B1 EP 2787065B1 EP 14158279 A EP14158279 A EP 14158279A EP 2787065 B1 EP2787065 B1 EP 2787065B1
Authority
EP
European Patent Office
Prior art keywords
weight
rhamnolipids
detergent formulation
formulation according
rhamnolipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP14158279.1A
Other languages
German (de)
French (fr)
Other versions
EP2787065A1 (en
Inventor
Dirk Kuppert
Ulrike Kottke
Jürgen LATTICH
Magdalena Volk
Hans Henning Wenk
Fabien Cabirol
Martin Schilling
Steffen Schaffer
Petra Allef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Degussa GmbH filed Critical Evonik Degussa GmbH
Publication of EP2787065A1 publication Critical patent/EP2787065A1/en
Application granted granted Critical
Publication of EP2787065B1 publication Critical patent/EP2787065B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/74Carboxylates or sulfonates esters of polyoxyalkylene glycols
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/02Anionic compounds
    • C11D1/04Carboxylic acids or salts thereof
    • C11D1/06Ether- or thioether carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/02Anionic compounds
    • C11D1/37Mixtures of compounds all of which are anionic

Definitions

  • the invention relates to detergent formulations for textiles containing rhamnolipids, wherein the content of di-rhamnolipids predominates, and the use of certain rhamnolipid mixture compositions and the aforementioned detergent formulations for accelerating foaming and / or foam stabilization and the use of rhamnolipids to prevent the graying of a textile.
  • Aqueous surfactant solutions show, depending on their composition, different rapid foam buildup and different foam stability. Foaming and decay are affected by the presence of dirt. Foam stability is an important quality feature for the consumer, especially when washing laundry or fabrics.
  • rhamnolipids (RL) with a high content of di-rhamnolipids in detergent formulations have a more stable foam and / or more foaming than surfactants according to the prior art, especially in the presence of high soil load.
  • the present invention therefore provides detergent formulations for textiles comprising a rhamnolipid mixture composition with an increased proportion of di-rhamnolipids, according to claim 1.
  • Another object of the invention is the use of certain rhamnolipid blend compositions and the aforementioned detergent formulations for accelerating foam formation and / or for foam stabilization and the use of rhamnolipids for preventing the graying of a textile according to claims 11-14.
  • An advantage of the invention is that the surfactants used are biodegradable in the detergent formulation.
  • An advantage of the formulations according to the invention is their outstanding foam stability in the aqueous.
  • Another advantage of the formulations according to the invention is their outstanding foam volume in the aqueous.
  • Another advantage of the formulations according to the invention is their excellent foaming behavior.
  • Another advantage of the formulations according to the invention is their ease of formulation in any aqueous, surfactant systems.
  • Another advantage of the formulations according to the invention is their good thickenability with conventional thickeners in formulations.
  • Another advantage is their good washability of textiles.
  • a further advantage of the formulations according to the invention is their mildness or good physiological compatibility, in particular characterized by a high value in the Red Blood Cell (RBC) test.
  • RBC Red Blood Cell
  • Another advantage of the formulations according to the invention is that they leave a pleasant soft feel of the textile after washing.
  • pH in the context of the present invention is defined as the value measured for corresponding substance at 25 ° C after five minutes of stirring with a pH electrode calibrated according to ISO 4319 (1977).
  • aqueous in the context of the present invention is to be understood as meaning a composition which contains at least 5% by weight of water, based on the total composition under consideration.
  • Claimed is thus a detergent formulation for textiles comprising a mono- and di-rhamnolipid mixture composition, characterized in that the weight ratio of di-rhamnolipids to mono-rhamnolipids greater than 97: 3, in particular greater than 98: 2.
  • the blend composition according to the invention contains mono-rhamnolipids.
  • the detergent formulation according to the invention is preferably liquid at room temperature.
  • the detergent formulation preferred according to the invention is characterized in that the rhamnolipid mixture composition 51 wt .-% to 95 wt .-%, preferably 70 wt .-% to 90 wt .-%, particularly preferably 75 wt .-% to 85 wt .-%, diRL-C10C10 and From 0.5% to 9% by weight, preferably from 0.5% to 3%, more preferably from 0.5% to 2%, by weight, mono Rl-C10C10 contains wherein the percentages by weight refer to the sum of all contained rhamnolipids,
  • the detergent formulation preferred according to the invention is characterized in that the rhamnolipid mixture composition contains, in addition to the abovementioned diRLC10C10 and monoRL-C10C10 contents From 0.5% to 15%, preferably from 3% to 12%, more preferably from 5% to 10%, by weight of the diRL-C10C12: 1 contains wherein the percentages by weight refer to the sum of all contained
  • the detergent formulation preferred according to the invention is characterized in that the rhamnolipid mixture composition contains, in addition to the abovementioned diRLC10C10 and monoRL-C10C10 contents 0.5 to 25 wt .-%, preferably 5 wt .-% to 15 wt .-%, particularly preferably 7 wt .-% to 12 wt .-%, diRL-C10C12 contains wherein the percentages by weight refer to the sum of all contained rhamnolipids.
  • the detergent formulation preferred according to the invention is characterized in that the rhamnolipid mixture composition contains, in addition to the abovementioned diRLC10C10 and monoRL-C10C10 contents From 0.1% by weight to 5% by weight, preferably from 0.5% by weight to 3% by weight, particularly preferably from 0.5% by weight to 2% by weight, of monoRL-C10C12 and / or, preferred and From 0.1% by weight to 5% by weight, preferably from 0.5% by weight to 3% by weight, particularly preferably from 0.5% by weight to 2% by weight, mono-C 10 -C 12: 1 . contains wherein the percentages by weight refer to the sum of all contained rhamnolipids.
  • the rhamnolipid mixture composition contained in the formulation according to the invention may contain, in addition to the abovementioned diRL-C10C10 and monoRL-C10C10 contents From 0.1% by weight to 25% by weight, preferably from 2% by weight to 10% by weight, particularly preferably from 4% by weight to 8% by weight, of diRL-C8C10, contains wherein the percentages by weight refer to the sum of all contained rhamnolipids.
  • a particularly preferred detergent formulation according to the invention is characterized in that the rhamnolipid mixture composition contains, in addition to the abovementioned diRL-C10C10 and monoRL-C10C10 contents From 0.5% to 15% by weight, preferably from 3% to 12% by weight, more preferably from 5% to 10% by weight, of diRL-C 10 C 12: 1, From 0.5% to 25% by weight, preferably from 5% by weight to 15% by weight, particularly preferably from 7% by weight to 12% by weight, of diRL-C10C12, 0.1 wt .-% to 5 wt .-%, preferably 0.5 wt .-% to 3 wt .-%, particularly preferably 0.5 wt .-% to 2 wt .-%, monoRL-C10C12 and From 0.1% by weight to 5% by weight, preferably from 0.5% by weight to 3% by weight, particularly preferably from 0.5% by weight to 2% by weight, mono-C 10 -C 12: 1 . contains
  • the rhamnolipid mixture composition contained in the formulation according to the invention contains rhamnolipids of the formula monoRL-CX or diRL-CX in only small amounts.
  • the mixture composition according to the invention preferably contains 0 wt .-% to 5 wt .-%, preferably 0 wt .-% to 3 wt .-%, particularly preferably 0 wt .-% to 1 wt .-%, diRLC10, wherein the weight percent based on the sum of all Rhamnolipids, and the term "0 wt .-%" is no detectable amount to understand.
  • the formulations of the invention are substantially free of fatty oil (at 20 ° C liquid acylglycerols) and thus in particular less than 0.5 wt .-%, in particular less than 0.1 wt .-%, particularly preferred no detectable levels of fatty oil based on the total blend composition.
  • the mixture compositions contained in the formulations according to the invention can be prepared by mixing the pure substances, wherein the pure substances from conventionally prepared rhamnolipid mixtures can be purified.
  • Corresponding purification methods are, for example, selective crystallizations and chromatographic methods.
  • Corresponding methods are in Heyd et al., Development and trends of biosurfactant analysis and purification using rhamnolipids as an example, Anal. Bioanal Chem. 2008 Jul; 391 (5): 1579-90 described.
  • inducible promoter is to be understood as meaning a promoter which changes its activity by altering the medium surrounding the cell. Changes may include, for example, temperature changes and concentration changes of certain substances.
  • inducing the at least one inducible promoter in the context of the present invention means that the activity of the inducible promoter is increased by a change in the medium surrounding the cell.
  • Suitable inducible promoters in the context of the present invention are, for example, promoters which are induced by the addition of chemical inducers (such as lactose, IPTG, dicyclopropyl ketone, tetracycline, doxycycline, propionate, cumate, benzoate, arabinose, rhamnose, nicotinic acid, etc.) altered environmental conditions (such as occurring phosphate or sulfur deficiency, altered temperatures or pH, etc.) are induced, or induced by certain physiological conditions (such as certain cell densities or growth rates or - phases).
  • chemical inducers such as lactose, IPTG, dicyclopropyl ketone, tetracycline, doxycycline, propionate, cumate, benzoate, arabinose, rhamnose, nicotinic acid, etc.
  • altered environmental conditions such as occurring phosphate or sulfur deficiency, altered temperatures or pH, etc.
  • physiological conditions such as certain cell
  • Particularly preferred inducible promoters used in the method are selected from the group of promoters inducible by dicyclopropyl ketone, tetracycline, doxycycline, propionate, cumate, benzoate, phosphate deficiency, sulfur deficiency or a reduced growth rate.
  • the genes rhIA, rhIB and rhIC are preferably selected in both of the methods described above from those from P. aeruginosa.
  • Preferred formulations according to the invention comprise, in addition to the rhamnolipid mixture composition, at least one further surfactant, it being possible to use, for example, anionic, nonionic, cationic and / or amphoteric surfactants, with anionic surfactants being preferred.
  • the total surfactant content of the formulation according to the invention is preferably from 5 to 40% by weight and more preferably from 9 to 35% by weight, based on the total formulation.
  • the nonionic surfactants used are preferably alkoxylated, advantageously ethoxylated, in particular primary, alcohols having preferably 8 to 18 carbon atoms and on average 1 to 12 moles of ethylene oxide (EO) per mole of alcohol, in which the alcohol radical can be linear or preferably methyl-branched in the 2-position or linear and methyl-branched radicals in the mixture can contain, as they are usually present in Oxoalkoholresten.
  • alcohol ethoxylates with linear radicals of alcohols of native origin having 12 to 18 carbon atoms, for example of coconut, palm, tallow or oleyl alcohol, and on average 2 to 8 EO per mole of alcohol are preferred.
  • the preferred ethoxylated alcohols include, for example, C12-C14 alcohols with 3 EO, 4 EO or 7 EO, C9-C11 alcohol with 7 EO, C13-C15 alcohols with 3 EO, 5 EO, 7 EO or 8 EO, C12 C18 alcohols with 3 EO, 5 EO or 7 EO and mixtures of these, such as mixtures of C12-C14 alcohol with 3 EO and C12-C18 alcohol with 7 EO.
  • the degrees of ethoxylation given represent statistical means which, for a particular product, may be an integer or a fractional number.
  • Preferred alcohol ethoxylates have a narrow homolog distribution.
  • fatty alcohols with more than 12 EO can also be used. Examples include tallow fatty alcohol with 14 EO, 25 EO, 30 EO or 40 EO.
  • Nonionic surfactants containing EO and PO (propylene oxide) groups together in the molecule can also be used.
  • block copolymers with EO-PO block units or PO-EO block units can be used, but also EO-PO-EO copolymers or PO-EO-PO copolymers.
  • alkyl glycosides can also be used as further nonionic surfactants.
  • Another class of preferred nonionic surfactants used either as the sole nonionic surfactant or in combination with other nonionic surfactants Surfactants are alkoxylated, preferably ethoxylated or ethoxylated and propoxylated Fettsaurealkylester, preferably having 1 to 4 carbon atoms in the alkyl chain, in particular fatty acid methyl esters, as described for example in Japanese Patent Application JP 58/217598 are described or preferably according to the in the international patent application WO 90/13533 be prepared described methods.
  • Nonionic surfactants of the amine oxide type for example N-cocoalkyl-N, N-dimethylamine oxide and N-tallowalkyl-N, N-dihydroxyethylamine oxide, and the fatty acid alkanolamides may also be suitable.
  • the amount of these nonionic surfactants is preferably not more than that of the ethoxylated fatty alcohols, especially not more than half thereof.
  • polyhydroxy fatty acid amides are substances which can usually be obtained by reductive amination of a reducing sugar with ammonia, an alkylamine or an alkanolamine and subsequent acylation with a fatty acid, a fatty acid alkyl ester or a fatty acid chloride.
  • the content of nonionic surfactants in the formulations according to the invention is preferably 5 to 30% by weight, preferably 7 to 20% by weight and in particular 9 to 15% by weight, based in each case on the entire formulation.
  • anionic surfactants for example, those of the sulfonate type and sulfates are used.
  • surfactants of the sulfonate type are preferably C9-C13-alkylbenzenesulfonates, olefinsulfonates, ie mixtures of alkene and hydroxyalkanesulfonates and disulfonates, such as those of C12-C18 monoolefins with terminal or internal double bond by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acid hydrolysis of the sulfonation obtained.
  • alkanesulfonates which are obtained from C 12 -C 18 alkanes, for example by sulfochlorination or sulfoxidation with subsequent hydrolysis or neutralization.
  • esters of ⁇ -sulfo fatty acids esters of ⁇ -sulfo fatty acids (ester sulfonates), for example the ⁇ -sulfonated methyl esters of hydrogenated coconut, palm kernel or tallow fatty acids.
  • anionic surfactants are sulfated fatty acid glycerol esters.
  • Fatty acid glycerol esters are to be understood as meaning the mono-, di- and triesters and mixtures thereof, as in the preparation by esterification of a monoglycerol with 1 to 3 mol fatty acid or in the transesterification of triglycerides with 0.3 to 2 mol Glycerol can be obtained.
  • Preferred sulfated fatty acid glycerol esters are the sulfonation products of saturated fatty acids having 6 to 22 carbon atoms, for example caproic acid, caprylic acid, capric acid, myristic acid, lauric acid, palmitic acid, stearic acid or behenic acid.
  • Alk (en) ylsulfates are the alkali metal salts and in particular the sodium salts of the sulfuric monoesters of C12-C18 fatty alcohols, for example coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl, cetyl or stearyl alcohol or the C10-C20 oxo alcohols and those half esters secondary Alcohols of these chain lengths are preferred. Also preferred are alk (en) ylsulfates of said chain length, which contain a synthetic, produced on a petrochemical basis straight-chain alkyl radical, which have an analogous degradation behavior as the adequate compounds based on oleochemical raw materials.
  • C12-C16 alkyl sulfates and C12-C18 alkyl sulfates and C14-C18 alkyl sulfates are preferred.
  • 2,3-alkyl sulfates which, for example, according to the U.S. Patents 3,234,258 or 5,075,041 and can be obtained as commercial products of the Shell Oil Company under the name DAN®, are suitable anionic surfactants.
  • sulfuric monoesters of ethoxylated with 1 to 6 moles of ethylene oxide straight or branched C7-C20 alcohols such as 2-methyl-branched C9-C11 alcohols having an average of 3.5 moles of ethylene oxide (EO) or C12-C18 fatty alcohols with 1 up to 4 EO, are suitable. Due to their high foaming behavior, they are only used in detergents in relatively small amounts, for example in amounts of from 1 to 5% by weight.
  • Suitable anionic surfactants are also the salts of alkylsulfosuccinic acid, which are also referred to as sulfosuccinates or as sulfosuccinic esters and the monoesters and / or diesters of sulfosuccinic acid with alcohols, preferably fatty alcohols and in particular ethoxylated fatty alcohols.
  • alcohols preferably fatty alcohols and in particular ethoxylated fatty alcohols.
  • Preferred sulfosuccinates contain C8-C18 fatty alcohol residues or mixtures of these.
  • Particularly preferred sulfosuccinates contain a fatty alcohol residue derived from ethoxylated fatty alcohols.
  • Sulfosuccinates whose fatty alcohol residues are derived from ethoxylated fatty alcohols with a narrow homolog distribution, are again particularly preferred.
  • alk (en) ylsuccinic acid having preferably 8 to 18 carbon atoms in the alk (en) yl chain or salts thereof.
  • Particularly preferred anionic surfactants are soaps. Suitable are saturated and unsaturated fatty acid soaps, such as the salts of lauric acid, myristic acid, Palmitic acid, stearic acid, (hydrogenated) erucic acid and behenic acid, and in particular soap mixtures derived from natural fatty acids, for example coconut, palm kernel, olive oil or tallow fatty acids.
  • the anionic surfactants including the soaps may be in the form of their sodium, potassium or ammonium salts and as soluble salts of organic bases such as mono-, di- or triethanolamine.
  • the anionic surfactants are preferably present in the form of their sodium or potassium salts, in particular in the form of the sodium salts.
  • the content of anionic surfactants of the formulation according to the invention is preferably 2 to 30 wt .-%, preferably 4 to 25 wt .-% and in particular 5 to 22 wt .-% based on the total formulation.
  • amphoteric surfactants such as surface-active compounds which carry at least one quaternary ammonium group and at least one -COO-- or -SO 3 - group in the molecule can be used as amphoteric surfactants.
  • amphoteric surfactants in this context are betaine surfactants such as alkyl or alkylamidopropyl betaines.
  • betaines such as the N-alkyl-N, N-dimethylammonium glycinate, z.
  • cocoalkyl dimethylammoniumglycinat N-acyl-aminopropyl-N, N-dimethylammoniumglycinate, z.
  • Cocoacylaminopropyldimethylammonium glycinate C12-C18-alkyl-dimethyl-acetobetaine, cocoamidopropyl-dimethyl-acetobetaine, 2-alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines and sulfobetaines each having 8 to 18 carbon atoms in the alkyl or acyl group, as well as cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a particularly preferred zwitterionic surfactant is the N, N-dimethyl-N- (lauroylamidopropyl) ammonium acetobetaine known by the INCI name Cocamidopropyl Betaine.
  • amphoteric surfactants are the group of amphoacetates and amphodiacetates, in particular coconut or laurylamphoacetates or diacetates, the group of amphopropionates and amphodipropionates and the group of amino acid-based surfactants such as acylglutamates, in particular disodium cocoyl glutamates and sodium cocoyl glutamates, acylglycinates, in particular cocoyl glycinates, and acyl sarcosinates, especially ammonium lauroyl sarcosinates and sodium cocoyl sarcosinates.
  • acylglutamates in particular disodium cocoyl glutamates and sodium cocoyl glutamates
  • acylglycinates in particular cocoyl glycinates
  • acyl sarcosinates especially ammonium lauroyl sarcosinates and sodium cocoyl sarcosinates.
  • Particularly preferred detergent formulations according to the invention are characterized in that the surfactant is selected from the group of sulfonates and Sulfates, preferably of the linear alkyl-benzene sulfonates, in particular from the group of C 9 - C 13 alkyl benzene sulfonates, most preferably sodium (nC 10 -C 13 ) alkyl benzene sulfonate.
  • the surfactant is selected from the group of sulfonates and Sulfates, preferably of the linear alkyl-benzene sulfonates, in particular from the group of C 9 - C 13 alkyl benzene sulfonates, most preferably sodium (nC 10 -C 13 ) alkyl benzene sulfonate.
  • the detergent formulations may contain other ingredients which further enhance the performance and / or aesthetics of the detergent formulation.
  • preferred detergent formulations additionally contain one or more substances from the group of builders, bleaches, bleach activators, enzymes, perfumes, perfume carriers, fluorescers, dyes, foam inhibitors, silicone oils, antiredeposition agents, optical brighteners, grayness inhibitors, anti-shrinkage agents, anti-crease agents, dye transfer inhibitors, antimicrobial agents, germicides, fungicides, antioxidants, preservatives, corrosion inhibitors, antistatic agents, bittering agents, ironing auxiliaries, repellents and impregnating agents, swelling and anti-slip agents, neutral filler salts and UV absorbers.
  • anti-wrinkling agents examples include anti-wrinkling agents, antimicrobial agents, germicides, fungicides, antioxidants, preservatives, antistatic agents, ironing aids, UV absorbers.
  • the detergent formulations may contain between 0.001 and 90, more preferably 0.01 to 45 wt .-% of one or more of the other ingredients mentioned herein, wherein the wt .-% refer to the total detergent formulation.
  • the detergent formulations according to the invention can advantageously be used to accelerate foam formation and / or foam stabilization.
  • the detergent formulations according to the invention are preferred for Foam stabilization used, this inventive use is carried out in particular in the presence of dirt.
  • rhamnolipid mixture compositions contained in the detergent formulations according to the invention for accelerating foam formation and / or for foam stabilization.
  • the rhamnolipid blend compositions contained in the detergent formulations according to the invention are used for foam stabilization, this use according to the invention being carried out in particular in the presence of dirt.
  • Another object of the present invention is the use of a detergent formulation according to the invention for preventing the graying of a textile and / or as an anti-redeposition agent.
  • Another object of the present invention is the use of a rhamnolipid blend composition according to claim 1 for preventing the graying of a textile and / or as an anti redeposition agent, wherein the rhamnolipid blend compositions contained in the detergent formulations according to the invention are used.
  • the rhamnolipid mixture compositions which are contained in the detergent formulations mentioned above as being preferred are particularly preferably used.
  • Example 1 Production of rhamnolipids with rhIABC from P. aeruginosa PAO1 in P. putida, wherein the expression of the gene coding for the rhamnosyltransferase RhIC is in many cases stronger than that of the gene RhIB coding for the rhamnosyltransferase RhIB
  • aeruginosa PAO1 genes rhIA, rhIB and rhIC followed by a terminator, followed by the synthetic tac promoter, followed by the P. aeruginosa PAO1 gene rhIC and a terminator flanked by Hin dIII - (5 'end) or Bsu 36I interface (3' end) ( SEQ ID NO: 2).
  • the vectors supplied by the DNA synthesis provider containing the synthesized DNA fragment are cleaved with Hin dIII and Bsu 36I and inserted into Hin dIII and Bsu 36I vector pBBR1 MCS-2 (Seq ID 3) by fast link ligation Kit (Epicenter Technologies, Madison, WI, USA).
  • the obtained target vector pBBR1MCS2-Plac-rhIABC-T-Ptac-rhIC-T (pBBR1 MCS-2 with synthesized fragment Seq ID No. 2) has a size of 9336 base pairs.
  • Recombinant strain P. putida KT2440 pBBR1 MCS2-Plac-rhIABC-T-Ptac-rhIC-T is cultured on LB agar kanamycin (50 ⁇ g / ml) plates.
  • M9 medium For the production of rhamnolipids, the medium referred to below as M9 medium is used. This medium consists of 2% (w / v) glucose, 0.3% (w / v) KH 2 PO 4 , 0.679% Na 2 HPO 4 , 0.05% (w / v) NaCl, 0.2% ( w / v) NH 4 Cl, 0.049% (w / v) MgSO 4 x 7 H 2 O and 0.1% (v / v) of a trace element solution.
  • a preculture is first prepared. For this purpose, a colony of a strain freshly streaked out on an LB agar plate is used and 10 ml of LB medium are inoculated in a 100 ml Erlenmeyer flask. All recombinant P. putida strains are cultured in LB medium to which 50 ⁇ g / ml kanamycin is added. The cultivation of the P. putida strains takes place at 30 ° C. and 200 rpm overnight.
  • the precultures are used to inoculate 50 ml of M9 medium (+ 50 ⁇ g / ml kanamycin) in the 250 ml Erlenmeyer flask (start OD 600 0.1).
  • the cultures are cultured at 200 rpm and 30 ° C. After 24 h, a sample of 1 ml of culture broth is removed from the culture flask.
  • a mineral medium (M9) is used for the main culture.
  • the fermentation after inoculation with 10 vol. % Pre-culture and consumption of the glucose is carbon-limited by means of a glucose feed in a 2 liter fermenter with a working volume of 1.2 l.
  • the glucose feed is based on the dissolved oxygen signal.
  • the dissolved oxygen is regulated at 20% saturation above the stirrer speed.
  • the pH is adjusted to 7 via a pH electrode and addition of NH 4 SO 4 .
  • the fermentation is carried out over 4 days to a dry biomass of 15 g / l.
  • the rhamnolipid concentration is determined by HPLC and is 9.8 g / l.
  • the fermentation broth is adjusted to a pH of 4.0 by adding concentrated HCl.
  • the mixture is then extracted with the same volume of ethyl acetate.
  • the rhamnolipid Web organic phase is separated and on processed.
  • KOH 50% strength by weight
  • the pH of the solution is adjusted to pH 7. This leads to the formation of two liquid phases.
  • the lower phase contains the liberated from lipophilic and hydrophilic impurities rhamnolipids in high purity.
  • the composition of the rhamnolipid mixture is not affected by this.
  • the lower phase is removed and the solvent removed as far as possible on a rotary evaporator.
  • water is added again and the aqueous rhamnolipid solution is freeze-dried.
  • the resulting powder is analyzed by means of HPLC and characterized by application technology.
  • Sample preparation for the subsequent chromatographic analyzes is carried out as follows: 1 ml of acetone is introduced into a 2 ml reaction vessel using a displacement pipette (Combitip) and the reaction vessel is immediately closed to minimize evaporation. This is followed by the addition of 1 ml of culture broth. After vortexing the culture broth / acetone mixture, this is centrifuged off for 3 min at 13,000 rpm and 800 ⁇ l of the supernatant are transferred to an HPLC vessel.
  • a displacement pipette Combitip
  • An Evaporative Light Scattering Detector (Sedex LT-ELSD Model 85LT) is used to detect and quantify rhamnolipids.
  • the actual measurement is performed using Agilent Technologies 1200 Series (Santa Clara, California) and the Zorbax SB-C8 Rapid Resolution column (4.6 x 150 mm, 3.5 ⁇ m, Agilent).
  • the injection volume is 5 ⁇ l and the runtime of the method is 20 min.
  • the mobile phase used is aqueous 0.1% TFA (trifluoroacetic acid, solution A) and methanol (solution B).
  • the column temperature is 40 ° C.
  • the detectors used are the ELSD (detector temperature 60 ° C) and the DAD (diode array, 210 nm).
  • the gradient used in the method is: t [min] Solution B vol .-% Flow [ml / min] 0.00 70% 1.00 15.00 100% 1.00 15,01 70% 1.00 20.00 70% 1.00
  • the rhamnolipid composition of P. putida KT2440 pBBR1MCS2-Plac-rhIABC-T-Ptac-rhIC-T obtained by the method described above contains: DIRL-C10C10 81% by weight DIRL-C10C12 10% by weight DIRL-C10C12: 1 8% by weight monoRL-C10C10 1% by weight resulting in a weight ratio of di-rhamnolipids to mono-rhamnolipids of 99: 1 results.
  • the stirrer with a holder for 4 closable cylinders with a volume of 300 ml is placed at an angle of 90 °.
  • the 300 ml measuring cylinder with closure are arranged so that the rotation of the cylinder is horizontal.
  • the measuring cylinders are wetted with the surfactant solution. This solution is then discarded.
  • each measuring cylinder 60 ml of surfactant solution to be tested are filled into each measuring cylinder as foam-free as possible.
  • the sealed graduated cylinders are mounted in the appropriate holders and the mixer started at 20 rpm. At the same time a stopwatch is pressed. In order to measure the foam heights as a function of time, the mixer is stopped after appropriate time intervals, waited 30 seconds, and noted the foam height.
  • the dirt is added at defined times.
  • the concentration of the surfactant is in all cases 0.4 g of active substance per liter of solution.
  • the solution was shaken for 2 minutes without addition of dirt in the cylinder. Then the first portion of dirt was added, then shaken for a further 10 min. After reading the foam height, the second addition of a defined amount of dirt took place and it was shaken again for 10 minutes. After reading the foam height, the third addition of a defined amount of dirt took place and it was shaken again for 10 minutes and the foam height was measured.
  • the measured foam heights represent mean values of 4 individual measurements.
  • the typical composition of the Standardschmutze is according to the company wfk Testgewebe GmbH as follows: 18.4% Olive oil (Olio Extra Vergine di Oliva) 18.4% Synthetic Sebum after Bey 9.4% kaolin 9.2% Protein (from protein powder) 8.0% Bleach consuming agent 6.9% Strength 6.9% salt 6.9% mineral oil 6.9% lanolin 2.8% Emulsifier (Uniperol® dispersant trade name of, BASF SE) 2.3% Urea (synthetic) 2.0% Quartz 1.8% calcium chloride 0.075% soot 0.025% iron oxide
  • LAS MARLON ARL ⁇ Sasol, sodium (nC 10 -C 13) -alkylbenzolsulphonat with an active content of 80 wt .-%, is a known, high foaming anion surfactant, which finds wide use in detergent formulations.
  • Jenil Commercial sample with a high mono-rhamnolipid content
  • Example 1 shows a somewhat slower foaming behavior, but reaches a similar level after 10 minutes as the anionic surfactant LAS.
  • Each with its high monoRL content and low diRL content exhibits a slower foaming behavior than Example 1, which has a low monoRL content and a high diRL content, and finally only achieves a significantly lower foam level than LAS or Example 1.
  • Example 2 With three additions (see Example 2) of 76 mg of dirt into a cylinder, the composition of Example 1 shows a slightly higher foam formation than LAS after 15 minutes compared to LAS. After the third dirt addition (after 20 min), the foam height is still stable and significantly higher than in LAS.
  • the reflectance of the test fabrics before and after washing is measured.
  • the brightness L *, the value a * on the red-green color axis and the value b * on the yellow-blue color axis before and after washing are measured with the aid of the CIE-Lab color space classification.
  • the change in the color value ( ⁇ E value) is a measure of the achieved cleaning effect.
  • AE value description > 2 Visually detectable reduction of contamination 4-10 Mediocre stain removal 10-20 Significant stain removal > 20 Complete stain removal
  • wash liquor Composition cf. Table below
  • Water hardness 16 ° dH
  • Asset load per wash tank 500 ml
  • Fabric load per wash tank 3 stains of a variety (10 x 10 cm) and 1 white cotton fabric (10 x 20 cm).
  • the size of the lobules should be adjusted to weigh about 10g along with the white cotton fabric.
  • Washing mechanics 10 steel balls ⁇ 6 mm Washing temperature: 25 ° C Washing time: 30 min Do the washing up: 3 x 30 s with tap water (about 5 ° dH)
  • Detergent formulation A Concentration% by weight (100% active base) Ex.1 37.60 glycerin 5 propylene glycol 9 triethanolamine 11.05 citric acid 1.71 water rest
  • the detergent formulations were adjusted to pH 8.2 with sodium hydroxide solution.
  • a detergent formulation containing as the effective surfactant excluding a composition of Example 1 is as effective in stain removal of soy, curry, carbon black and skin fat as a commercial liquid detergent based on an optimized surfactant ratio of LAS, other anionic surfactants and nonionic surfactants.
  • rhamnolipids of the specific composition of Example 1 show a less graying effect on curry, soot, milk / cocoa than the commercial LAS-based liquid detergent and thus act as anti-redeposition agents.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Detergent Compositions (AREA)

Description

Gebiet der ErfindungField of the invention

Gegenstand der Erfindung sind Waschmittelformulierungen für Textilien enthaltend Rhamnolipide, wobei der Gehalt an di-Rhamnolipiden überwiegt, sowie die Verwendung von bestimmten Rhamnolipid-Mischungszusammensetzungen und der vorgenannten Waschmittelformulierungen zur Beschleunigung von Schaumentstehung und/oder zur Schaumstabilisierung sowie die Verwendung von Rhamnolipiden zur Verhinderung der Vergrauung eines Textils.The invention relates to detergent formulations for textiles containing rhamnolipids, wherein the content of di-rhamnolipids predominates, and the use of certain rhamnolipid mixture compositions and the aforementioned detergent formulations for accelerating foaming and / or foam stabilization and the use of rhamnolipids to prevent the graying of a textile.

Stand der TechnikState of the art

Wässrige Tensidlösungen zeigen in Abhängigkeit ihrer Zusammensetzung unterschiedlich schnellen Schaumaufbau und eine unterschiedliche Schaumstabilität. Schaumbildung und -zerfall werden durch die Anwesenheit von Schmutz beeinflusst. Schaumstabilität ist insbesondere beim Waschen von Wäsche bzw. Gewebe ein für den Verbraucher wichtiges Qualitätsmerkmal.Aqueous surfactant solutions show, depending on their composition, different rapid foam buildup and different foam stability. Foaming and decay are affected by the presence of dirt. Foam stability is an important quality feature for the consumer, especially when washing laundry or fabrics.

Wünschenswert sind Waschmittelformulierungen mit hoher Schaumstabilität. Überraschend wurde gefunden, dass Rhamnolipide (RL) mit einem hohen Gehalt an di- Rhamnolipiden in Waschmittelformulierungen einen stabileren Schaum und/oder mehr Schaumbildung zeigen als Tenside nach dem Stand der Technik, insbesondere in Gegenwart von hoher Schmutzlast.Desirable are detergent formulations with high foam stability. Surprisingly, it has been found that rhamnolipids (RL) with a high content of di-rhamnolipids in detergent formulations have a more stable foam and / or more foaming than surfactants according to the prior art, especially in the presence of high soil load.

Beschreibung der ErfindungDescription of the invention

Überraschenderweise wurde gefunden, dass die im Folgenden beschriebenen Formulierungen die der Erfindung gestellt Aufgabe zu lösen vermögen. Gegenstand der vorliegenden Erfindung sind daher Waschmittelformulierungen für Textilien enthaltend eine Rhamnolipid-Mischungszusammensetzung mit einem erhöhten Anteil an di-Rhamnolipiden, gemäß Anspruch 1. Ein weiterer Gegenstand der Erfindung ist die Verwendung von bestimmten Rhamnolipid-Mischungszusammensetzungen und der vorgenannten Waschmittelformulierungen zur Beschleunigung von Schaumentstehung und/oder zur Schaumstabilisierung sowie die Verwendung von Rhamnolipiden zur Verhinderung der Vergrauung eines Textils gemäß den Ansprüchen 11-14.Surprisingly, it has been found that the formulations described below are capable of solving the problem set by the invention. The present invention therefore provides detergent formulations for textiles comprising a rhamnolipid mixture composition with an increased proportion of di-rhamnolipids, according to claim 1. Another object of the invention is the use of certain rhamnolipid blend compositions and the aforementioned detergent formulations for accelerating foam formation and / or for foam stabilization and the use of rhamnolipids for preventing the graying of a textile according to claims 11-14.

Ein Vorteil der Erfindung ist es, dass die eingesetzten Tenside in der Waschmittelformulierung biologisch abbaubar sind.An advantage of the invention is that the surfactants used are biodegradable in the detergent formulation.

Ein Vorteil der erfindungsgemäßen Formulierungen ist deren überragende Schaumstabilität im Wässrigen.An advantage of the formulations according to the invention is their outstanding foam stability in the aqueous.

Noch ein Vorteil der erfindungsgemäßen Formulierungen ist deren überragendes Schaumvolumen im Wässrigen.Another advantage of the formulations according to the invention is their outstanding foam volume in the aqueous.

Ein weiterer Vorteil der erfindungsgemäßen Formulierungen ist deren hervorragendes Anschäumverhalten.Another advantage of the formulations according to the invention is their excellent foaming behavior.

Noch ein Vorteil der erfindungsgemäßen Formulierungen ist deren einfache Formulierbarkeit in beliebigen wässrigen, tensidischen Systemen.Another advantage of the formulations according to the invention is their ease of formulation in any aqueous, surfactant systems.

Ein weiterer Vorteil der erfindungsgemäßen Formulierungen ist deren gute Verdickbarkeit mit konventionellen Verdickern in Formulierungen.Another advantage of the formulations according to the invention is their good thickenability with conventional thickeners in formulations.

Noch ein Vorteil ist ihre gute Auswaschbarkeit von Textilien.Another advantage is their good washability of textiles.

Ein weiterer Vorteil der erfindungsgemäßen Formulierungen ist ihre Mildheit bzw. gute physiologische Verträglichkeit, insbesondere charakterisiert durch einen hohen Wert im Red Blood-Cell (RBC) Test.A further advantage of the formulations according to the invention is their mildness or good physiological compatibility, in particular characterized by a high value in the Red Blood Cell (RBC) test.

Ein weiterer Vorteil der erfindungsgemäßen Formulierungen ist, dass sie einen angenehmen Weichgriff des Textils nach dem Waschen hinterlassen.Another advantage of the formulations according to the invention is that they leave a pleasant soft feel of the textile after washing.

Unter dem Begriff "Rhamnolipid" im Zusammenhang mit der vorliegenden Erfindung werden insbesondere Verbindungen der allgemeinen Formel (I) oder deren Salze verstanden,

Figure imgb0001
wobei

  • m = 2, 1 oder 0,
  • n = 1 oder 0,
  • R1 und R2 = unabhängig voneinander gleicher oder verschiedener organischer Rest mit 2 bis 24, bevorzugt 5 bis 13 Kohlenstoffatomen, insbesondere gegebenenfalls verzweigter, gegebenenfalls substituierter, insbesondere hydroxy-substituierter, gegebenenfalls ungesättigter, insbesondere gegebenenfalls einfach, zweifach oder dreifach ungesättigter, Alkylrest, bevorzugt solcher ausgewählt aus der Gruppe bestehend aus Pentenyl, Heptenyl, Nonenyl, Undecenyl und Tridecenyl und (CH2)o-CH3 mit o = 1 bis 23, bevorzugt 4 bis 12.
The term "rhamnolipid" in connection with the present invention is understood in particular to mean compounds of the general formula (I) or their salts,
Figure imgb0001
in which
  • m = 2, 1 or 0,
  • n = 1 or 0,
  • R 1 and R 2 = independently of one another the same or different organic radical having 2 to 24, preferably 5 to 13 carbon atoms, in particular optionally branched, optionally substituted, in particular hydroxy-substituted, optionally unsaturated, in particular optionally mono-, di- or triunsaturated, alkyl radical, preferably those selected from the group consisting of pentenyl, heptenyl, nonenyl, undecenyl and tridecenyl and (CH 2 ) o -CH 3 where o = 1 to 23, preferably 4 to 12.

Unter dem Begriff "di-Rhamnolipid" im Zusammenhang mit der vorliegenden Erfindung werden Verbindungen der allgemeinen Formel (I) oder deren Salze verstanden, bei denen n =1.The term "di-rhamnolipid" in connection with the present invention means compounds of the general formula (I) or their salts in which n = 1.

Unter dem Begriff "mono-Rhamnolipid" im Zusammenhang mit der vorliegenden Erfindung werden Verbindungen der allgemeinen Formel (I) oder deren Salze verstanden, bei denen n =0.The term "mono-rhamnolipid" in connection with the present invention means compounds of the general formula (I) or their salts in which n = 0.

Distinkte Rhamnolipide werden gemäß folgender Nomenklatur abgekürzt:

  • Unter "diRL-CXCY" werden di-Rhamnolipide der allgemeinen Formel (I) verstanden, bei denen einer der Reste R1 und R2 = (CH2)o-CH3 mit o = X-4 und der verbleibende Rest R1 oder R2 = (CH2)o-CH3 mit o = Y-4.
Distinct rhamnolipids are abbreviated according to the following nomenclature:
  • By "diRL-CXCY" di-rhamnolipids of the general formula (I) are understood, in which one of the radicals R 1 and R 2 = (CH 2 ) o -CH 3 with o = X-4 and the remaining radical R 1 or R 2 = (CH 2 ) o -CH 3 with o = Y-4.

Unter "monoRL-CXCY" werden mono-Rhamnolipide der allgemeinen Formel (I) verstanden, bei denen einer der Reste R1 und R2 = (CH2)o-CH3 mit o = X-4 und der verbleibende Rest R1 oder R2 = (CH2)o-CH3 mit o = Y-4."Mono R-CXCY" is understood as meaning mono rhamnolipids of the general formula (I) in which one of the radicals R 1 and R 2 = (CH 2 ) o -CH 3 with o = X-4 and the remainder R 1 or R 2 = (CH 2 ) o -CH 3 with o = Y-4.

Die verwendete Nomenklatur unterscheidet somit nicht zwischen "CXCY" und "CYCX". Für Rhamnolipide mit m=0 wird entsprechend monoRL-CX bzw. diRL-CX verwendet. Ist einer der oben genannten Indices X und/oder Y mit ":Z" versehen, so bedeutet dies, dass der jeweilige Rest R1 und/oder R2 = ein unverzweigter, unsubstituierter Kohlenwasserstoffrest mit X-3 bzw. Y-3 Kohlenstoffatomen aufweisend Z Doppelbindungen darstellt.The nomenclature used does not distinguish between "CXCY" and "CYCX". For rhamnolipids with m = 0, correspondingly monoRL-CX or diRL-CX is used. If one of the abovementioned indices X and / or Y is provided with ": Z", this means that the respective radical R 1 and / or R 2 = has an unbranched, unsubstituted hydrocarbon radical with X-3 or Y-3 carbon atoms Z represents double bonds.

Der "pH-Wert" im Zusammenhang mit der vorliegenden Erfindung ist definiert als der Wert, welcher für entsprechenden Stoff bei 25 °C nach fünf Minuten Rühren mit einer gemäß ISO 4319 (1977) kalibrierten pH-Elektrode gemessen wird.The "pH" in the context of the present invention is defined as the value measured for corresponding substance at 25 ° C after five minutes of stirring with a pH electrode calibrated according to ISO 4319 (1977).

Unter dem Begriff "wässriges" im Zusammenhang mit der vorliegenden Erfindung ist eine Zusammensetzung zu verstehen, die mindestens 5 Gew.-% Wasser, bezogen auf die betrachtete Gesamtzusammensetzung enthält.The term "aqueous" in the context of the present invention is to be understood as meaning a composition which contains at least 5% by weight of water, based on the total composition under consideration.

Alle angegebenen Prozent (%) sind, wenn nicht anders angegeben, Massenprozent. Beansprucht wird somit eine Waschmittelformulierung für Textilien enthaltend eine mono- und di-Rhamnolipid-Mischungszusammensetzung, dadurch gekennzeichnet, dass das Gewichtsverhältnis von di-Rhamnolipiden zu mono-Rhamnolipiden größer als 97:3, insbesondere größer 98:2 ist.All percentages (%) are by mass unless otherwise specified. Claimed is thus a detergent formulation for textiles comprising a mono- and di-rhamnolipid mixture composition, characterized in that the weight ratio of di-rhamnolipids to mono-rhamnolipids greater than 97: 3, in particular greater than 98: 2.

Durch den Begriff "mono- und di-Rhamnolipid-Mischungszusammensetzung" im Zusammenhang mit der vorliegenden Erfindung ist herausgestellt, dass die erfindungsgemäße Mischungszusammensetzung mono-Rhamnolipide enthält. Bevorzugt ist die erfindungsgemäße Waschmittelformulierung bei Raumtemperatur flüssig.By the term "mono- and di-rhamnolipid blend composition" in the context of the present invention, it is pointed out that the blend composition according to the invention contains mono-rhamnolipids. The detergent formulation according to the invention is preferably liquid at room temperature.

Erfindungsgemäß bevorzugte Waschmittelformulierung ist dadurch gekennzeichnet, dass die Rhamnolipid-Mischungszusammensetzung
51 Gew.-% bis 95 Gew.-%, bevorzugt 70 Gew.-% bis 90 Gew.-%, besonders bevorzugt 75 Gew.-% bis 85 Gew.-%, diRL-C10C10 und
0,5 Gew.-% bis 9 Gew.-%, bevorzugt 0,5 Gew.-% bis 3 Gew.-%, besonders bevorzugt 0,5 Gew.-% bis 2 Gew.-%, monoRL-C10C10
enthält,
wobei sich die Gewichtsprozente auf die Summe aller enthaltenen Rhamnolipide beziehen, Erfindungsgemäß bevorzugte Waschmittelformulierung ist dadurch gekennzeichnet, dass die Rhamnolipid-Mischungszusammensetzung neben den oben genannten diRLC10C10- und monoRL-C10C10 Gehalten
0,5 Gew.-% bis 15 Gew.-%, bevorzugt 3 Gew.-% bis 12 Gew.-%, besonders bevorzugt 5 Gew.-% bis 10 Gew.-%, diRL-C10C12:1
enthält,
wobei sich die Gewichtsprozente auf die Summe aller enthaltenen Rhamnolipide beziehen.
The detergent formulation preferred according to the invention is characterized in that the rhamnolipid mixture composition
51 wt .-% to 95 wt .-%, preferably 70 wt .-% to 90 wt .-%, particularly preferably 75 wt .-% to 85 wt .-%, diRL-C10C10 and
From 0.5% to 9% by weight, preferably from 0.5% to 3%, more preferably from 0.5% to 2%, by weight, mono Rl-C10C10
contains
wherein the percentages by weight refer to the sum of all contained rhamnolipids, The detergent formulation preferred according to the invention is characterized in that the rhamnolipid mixture composition contains, in addition to the abovementioned diRLC10C10 and monoRL-C10C10 contents
From 0.5% to 15%, preferably from 3% to 12%, more preferably from 5% to 10%, by weight of the diRL-C10C12: 1
contains
wherein the percentages by weight refer to the sum of all contained rhamnolipids.

Erfindungsgemäß bevorzugte Waschmittelformulierung ist dadurch gekennzeichnet, dass die Rhamnolipid-Mischungszusammensetzung neben den oben genannten diRLC10C10- und monoRL-C10C10 Gehalten
0,5 bis 25 Gew.-%, bevorzugt 5 Gew.-% bis 15 Gew.-%, besonders bevorzugt 7 Gew.-% bis 12 Gew.-%, diRL-C10C12
enthält,
wobei sich die Gewichtsprozente auf die Summe aller enthaltenen Rhamnolipide beziehen.
The detergent formulation preferred according to the invention is characterized in that the rhamnolipid mixture composition contains, in addition to the abovementioned diRLC10C10 and monoRL-C10C10 contents
0.5 to 25 wt .-%, preferably 5 wt .-% to 15 wt .-%, particularly preferably 7 wt .-% to 12 wt .-%, diRL-C10C12
contains
wherein the percentages by weight refer to the sum of all contained rhamnolipids.

Erfindungsgemäß bevorzugte Waschmittelformulierung ist dadurch gekennzeichnet, dass die Rhamnolipid-Mischungszusammensetzung neben den oben genannten diRLC10C10- und monoRL-C10C10 Gehalten
0,1 Gew.-% bis 5 Gew.-%, bevorzugt 0,5 Gew.-% bis 3 Gew.-%, besonders bevorzugt 0,5 Gew.-% bis 2 Gew.-%, monoRL-C10C12 und/oder, bevorzugt und
0,1 Gew.-% bis 5 Gew.-%, bevorzugt 0,5 Gew.-% bis 3 Gew.-%, besonders bevorzugt 0,5 Gew.-% bis 2 Gew.-%, monoRL-C10C12:1,
enthält,
wobei sich die Gewichtsprozente auf die Summe aller enthaltenen Rhamnolipide beziehen.
The detergent formulation preferred according to the invention is characterized in that the rhamnolipid mixture composition contains, in addition to the abovementioned diRLC10C10 and monoRL-C10C10 contents
From 0.1% by weight to 5% by weight, preferably from 0.5% by weight to 3% by weight, particularly preferably from 0.5% by weight to 2% by weight, of monoRL-C10C12 and / or, preferred and
From 0.1% by weight to 5% by weight, preferably from 0.5% by weight to 3% by weight, particularly preferably from 0.5% by weight to 2% by weight, mono-C 10 -C 12: 1 .
contains
wherein the percentages by weight refer to the sum of all contained rhamnolipids.

Es kann vorteilhaft sein und ist daher bevorzugt, wenn die in der erfindungsgemäßen Formulierung enthaltene Rhamnolipid-Mischungszusammensetzung neben den oben genannten diRL-C10C10- und monoRL-C10C10 Gehalten
0,1 Gew.-% bis 25 Gew.-%, bevorzugt 2 Gew.-% bis 10 Gew.-%, besonders bevorzugt 4 Gew.-% bis 8 Gew.-%, diRL-C8C10,
enthält,
wobei sich die Gewichtsprozente auf die Summe aller enthaltenen Rhamnolipide beziehen.
It may be advantageous, and is therefore preferred, for the rhamnolipid mixture composition contained in the formulation according to the invention to contain, in addition to the abovementioned diRL-C10C10 and monoRL-C10C10 contents
From 0.1% by weight to 25% by weight, preferably from 2% by weight to 10% by weight, particularly preferably from 4% by weight to 8% by weight, of diRL-C8C10,
contains
wherein the percentages by weight refer to the sum of all contained rhamnolipids.

Erfindungsgemäß besonders bevorzugte Waschmittelformulierung ist dadurch gekennzeichnet, dass die Rhamnolipid-Mischungszusammensetzung neben den oben genannten diRL-C10C10- und monoRL-C10C10 Gehalten
0,5 Gew.-% bis 15 Gew.-%, bevorzugt 3 Gew.-% bis 12 Gew.-%, besonders bevorzugt 5 Gew.-% bis 10 Gew.-%, diRL-C10C12:1,
0,5 bis 25 Gew.-%, bevorzugt 5 Gew.-% bis 15 Gew.-%, besonders bevorzugt 7 Gew.-% bis 12 Gew.-%, diRL-C10C12,
0,1 Gew.-% bis 5 Gew.-%, bevorzugt 0,5 Gew.-% bis 3 Gew.-%, besonders bevorzugt 0,5 Gew.-% bis 2 Gew.-%, monoRL-C10C12 und
0,1 Gew.-% bis 5 Gew.-%, bevorzugt 0,5 Gew.-% bis 3 Gew.-%, besonders bevorzugt 0,5 Gew.-% bis 2 Gew.-%, monoRL-C10C12:1,
enthält,
wobei sich die Gewichtsprozente auf die Summe aller enthaltenen Rhamnolipide beziehen.
A particularly preferred detergent formulation according to the invention is characterized in that the rhamnolipid mixture composition contains, in addition to the abovementioned diRL-C10C10 and monoRL-C10C10 contents
From 0.5% to 15% by weight, preferably from 3% to 12% by weight, more preferably from 5% to 10% by weight, of diRL-C 10 C 12: 1,
From 0.5% to 25% by weight, preferably from 5% by weight to 15% by weight, particularly preferably from 7% by weight to 12% by weight, of diRL-C10C12,
0.1 wt .-% to 5 wt .-%, preferably 0.5 wt .-% to 3 wt .-%, particularly preferably 0.5 wt .-% to 2 wt .-%, monoRL-C10C12 and
From 0.1% by weight to 5% by weight, preferably from 0.5% by weight to 3% by weight, particularly preferably from 0.5% by weight to 2% by weight, mono-C 10 -C 12: 1 .
contains
wherein the percentages by weight refer to the sum of all contained rhamnolipids.

Es ist überdies hinaus bevorzugt, wenn die in der erfindungsgemäßen Formulierung enthaltene Rhamnolipid-Mischungszusammensetzung Rhamnolipide der Formel monoRL-CX bzw. diRL-CX in nur kleinen Mengen enthält. Insbesondere enthält die erfindungsgemäße Mischungszusammensetzung bevorzugt
0 Gew.-% bis 5 Gew.-%, bevorzugt 0 Gew.-% bis 3 Gew.-%, besonders bevorzugt 0 Gew.-% bis 1 Gew.-%, diRLC10, wobei sich die Gewichtsprozente auf die Summe aller enthaltenen Rhamnolipide beziehen, und unter dem Begriff "0 Gew.-%" keine nachweisbare Menge zu verstehen ist.
Furthermore, it is preferred if the rhamnolipid mixture composition contained in the formulation according to the invention contains rhamnolipids of the formula monoRL-CX or diRL-CX in only small amounts. In particular, the mixture composition according to the invention preferably contains
0 wt .-% to 5 wt .-%, preferably 0 wt .-% to 3 wt .-%, particularly preferably 0 wt .-% to 1 wt .-%, diRLC10, wherein the weight percent based on the sum of all Rhamnolipids, and the term "0 wt .-%" is no detectable amount to understand.

Es ist erfindungsgemäß bevorzugt, dass die erfindungsgemäßen Formulierungen im Wesentlichen frei von fettem Öl (bei 20 °C flüssigen Acylglycerolen) sind und somit insbesondere weniger als 0,5 Gew.-%, insbesondere weniger als 0,1 Gew.-%, besonders bevorzugt keine nachweisbaren Mengen fettes Öl bezogen auf die gesamte Mischungszusammensetzung enthalten.It is inventively preferred that the formulations of the invention are substantially free of fatty oil (at 20 ° C liquid acylglycerols) and thus in particular less than 0.5 wt .-%, in particular less than 0.1 wt .-%, particularly preferred no detectable levels of fatty oil based on the total blend composition.

Die in den erfindungsgemäßen Formulierungen enthaltenen Mischungszusammensetzungen lassen sich durch Abmischen der Reinsubstanzen herstellen, wobei die Reinsubstanzen aus herkömmlich hergestellten Rhamnolipid-Mischungen aufgereinigt werden können. Entsprechende Aufreinigungsverfahren sind beispielsweise selektive Kristallisationen und chromatographische Methoden. Entsprechende Verfahren sind in Heyd et al., Development and trends of biosurfactant analysis and purification using rhamnolipids as an example, Anal Bioanal Chem. 2008 Jul;391(5):1579-90 beschrieben.The mixture compositions contained in the formulations according to the invention can be prepared by mixing the pure substances, wherein the pure substances from conventionally prepared rhamnolipid mixtures can be purified. Corresponding purification methods are, for example, selective crystallizations and chromatographic methods. Corresponding methods are in Heyd et al., Development and trends of biosurfactant analysis and purification using rhamnolipids as an example, Anal. Bioanal Chem. 2008 Jul; 391 (5): 1579-90 described.

Insbesondere die im Folgenden beschriebenen Verfahren eignen sich zur Herstellung von den in den erfindungsgemäßen Formulierungen enthaltenen Mischungszusammensetzungen.In particular, the processes described below are suitable for the preparation of the mixture compositions contained in the formulations according to the invention.

Ein erstes Verfahren umfasst die Verfahrensschritte:

  1. Ia) Bereitstellen einer Pseudomonas putida Zelle, die derart gentechnisch verändert wurde, dass sie jeweils mindestens ein Gen der Gruppe rhIA, rhIB und rhIC überexprimiert,
    • IIa) in Kontakt Bringen der erfindungsgemäßen Zelle mit einem Medium beinhaltend mindestens eine Kohlenstoffquelle
    • IIIa) Kultivieren der Zelle unter Bedingungen, die es der Zelle ermöglichen, aus der Kohlenstoffquelle Rhamnolipid zu bilden und
    • IVa) gegebenenfalls Isolierung der gebildeten Rhamnolipide,
      dadurch gekennzeichnet, dass das Gen rhIC verglichen zu rhIB stärker, insbesondere mindestens 1,5-fach, bevorzugt mindestens 2-fach, besonders bevorzugt mindestens 10-fach stärker, überexprimiert wird.
      Die relative Stärke der oben beschriebenen Überexpression lässt sich beispielsweise mit Hilfe von RT-PCR bestimmen, bei der die Menge an gebildeter mRNA für das jeweilige Gen bestimmt wird.
      Eine Regulierung der Stärke der Expression kann der Fachmann gezielt beispielsweise durch die Wahl von Promotoren oder durch den Einsatz induzierbarer Promotoren in Kombination mit Menge an Induktor erreichen oder auch durch Genvervielfachungen. Ein alternatives Verfahren umfasst die Verfahrensschritte:
  2. Ib) Bereitstellen einer Pseudomonas putida Zelle, die derart gentechnisch verändert wurde, dass sie jeweils mindestens ein exogenes Gen der Gruppe rhIA, rhIB und rhIC, von denen mindestens eines unter der Kontrolle eines induzierbaren Promotors steht, aufweist,
    • IIb) in Kontakt Bringen und Kultivieren der erfindungsgemäßen Zelle mit einem Medium beinhaltend mindestens eine Kohlenstoffquelle unter Erreichung einer Zelldichte von 1-30 g Zelltrockenmasse pro L Fermentationsbrühe, bevorzugt 2-20 g Zelltrockenmasse pro L Fermentationsbrühe, besonders bevorzugt 5-15 g Zelltrockenmasse pro L Fermentationsbrühe,
    • IIIb) Induzieren des mindestens einen induzierbaren Promotors und Kultivieren der Zelle unter Bedingungen, die es der Zelle ermöglichen, aus der Kohlenstoffquelle Rhamnolipid zu bilden und
    • IVb) gegebenenfalls Isolierung der gebildeten Rhamnolipide.
A first method comprises the method steps:
  1. Ia) providing a Pseudomonas putida cell genetically engineered to overexpress at least one of the groups rhIA, rhIB and rhIC,
    • IIa) contacting the cell of the invention with a medium containing at least one carbon source
    • IIIa) culturing the cell under conditions that allow the cell to form rhamnolipid from the carbon source and
    • IVa) if appropriate, isolation of the rhamnolipids formed,
      characterized in that the gene rhIC is more strongly overexpressed compared to rhIB, in particular at least 1.5-fold, preferably at least 2-fold, particularly preferably at least 10-fold stronger.
      The relative strength of the overexpression described above can be determined, for example, by means of RT-PCR, in which the amount of mRNA formed for the respective gene is determined.
      Regulation of the level of expression can be achieved by a person skilled in the art, for example, by the choice of promoters or by the use of inducible promoters in combination with the amount of inducer or by gene multiplication. An alternative method comprises the method steps:
  2. Ib) providing a Pseudomonas putida cell genetically engineered to each have at least one exogenous gene of group rhIA, rhIB and rhIC, at least one of which is under the control of an inducible promoter,
    • IIb) bringing into contact and cultivating the cell according to the invention with a medium containing at least one carbon source to reach a cell density of 1-30 g of cell dry matter per L of fermentation broth, preferably 2-20 g Dry cell mass per L of fermentation broth, more preferably 5-15 g of cell dry mass per L of fermentation broth,
    • IIIb) inducing the at least one inducible promoter and culturing the cell under conditions that allow the cell to form rhamnolipid from the carbon source and
    • IVb) if appropriate, isolation of the rhamnolipids formed.

Unter dem Begriff "induzierbarer Promotor" ist im Zusammenhang mit der vorliegenden Erfindung ein Promotor zu verstehen, der durch eine Veränderung des die Zelle umgebenden Mediums seine Aktivität ändert. Veränderungen können zum Beispiel Temperaturänderungen und Konzentrationsänderungen von bestimmten Substanzen umfassen.In the context of the present invention, the term "inducible promoter" is to be understood as meaning a promoter which changes its activity by altering the medium surrounding the cell. Changes may include, for example, temperature changes and concentration changes of certain substances.

Unter dem Begriff "Induzieren des mindestens einen induzierbaren Promotors" ist im Zusammenhang mit der vorliegenden Erfindung zu verstehen, dass die Aktivität des induzierbaren Promotors durch eine Veränderung des die Zelle umgebenden Mediums erhöht wird.The term "inducing the at least one inducible promoter" in the context of the present invention means that the activity of the inducible promoter is increased by a change in the medium surrounding the cell.

Geeignete induzierbare Promotoren im Zusammenhang mit der vorliegenden Erfindung sind beispielsweise Promotoren, die durch Zugabe chemischer Induktoren (etwa Laktose, IPTG, Dicyclopropylketon, Tetracyclin, Doxycyclin, Propionat, Cumat, Benzoat, Arabinose, Rhamnose, Nikotinsäure, etc.) induziert werden, die durch veränderte Umweltbedingungen (etwa auftretender Phosphat- oder Schwefelmangel, veränderte Temperaturen oder pH, etc.) induziert werden, oder die durch bestimmte physiologische Zustände (etwa bestimmte Zelldichten oder Wachstumsraten bzw. - phasen) induziert werden.
Insbesondere bevorzugt in dem Verfahren eingesetzte induzierbare Promotoren sind ausgewählt aus der Gruppe der durch Dicyclopropylketon, Tetracyclin, Doxycyclin, Propionat, Cumat, Benzoat, Phosphatmangel, Schwefelmangel oder eine verminderte Wachstumsrate induzierbaren Promotoren.
Die Gene rhIA, rhIB und rhIC sind in beiden oben beschriebenen Verfahren bevorzugt ausgewählt aus denen aus P. aeruginosa.
Suitable inducible promoters in the context of the present invention are, for example, promoters which are induced by the addition of chemical inducers (such as lactose, IPTG, dicyclopropyl ketone, tetracycline, doxycycline, propionate, cumate, benzoate, arabinose, rhamnose, nicotinic acid, etc.) altered environmental conditions (such as occurring phosphate or sulfur deficiency, altered temperatures or pH, etc.) are induced, or induced by certain physiological conditions (such as certain cell densities or growth rates or - phases).
Particularly preferred inducible promoters used in the method are selected from the group of promoters inducible by dicyclopropyl ketone, tetracycline, doxycycline, propionate, cumate, benzoate, phosphate deficiency, sulfur deficiency or a reduced growth rate.
The genes rhIA, rhIB and rhIC are preferably selected in both of the methods described above from those from P. aeruginosa.

Bevorzugte erfindungsgemäße Formulierungen enthalten neben der Rhamnolipid-Mischungszusammensetzung mindestens ein weiteres Tensid, wobei beispielsweise anionische, nichtionische, kationische und/oder amphotere Tenside eingesetzt werden können, wobei anionische Tenside bevorzugt sind.Preferred formulations according to the invention comprise, in addition to the rhamnolipid mixture composition, at least one further surfactant, it being possible to use, for example, anionic, nonionic, cationic and / or amphoteric surfactants, with anionic surfactants being preferred.

Bevorzugt sind aus anwendungstechnischer Sicht Mischungen aus anionischen und nichtionischen Tensiden in den erfindungsgemäßen Formulierungen enthalten.
Der Gesamttensidgehalt der erfindungsgemäßen Formulierung beträgt vorzugsweise 5 bis 40 Gew.-% und besonders bevorzugt 9 bis 35 Gew.-%, bezogen auf die gesamte Formulierung.
From an application point of view, preference is given to mixtures of anionic and nonionic surfactants in the formulations according to the invention.
The total surfactant content of the formulation according to the invention is preferably from 5 to 40% by weight and more preferably from 9 to 35% by weight, based on the total formulation.

Als nichtionische Tenside werden vorzugsweise alkoxylierte, vorteilhafterweise ethoxylierte, insbesondere primäre Alkohole mit vorzugsweise 8 bis 18 C-Atomen und durchschnittlich 1 bis 12 Mol Ethylenoxid (EO) pro Mol Alkohol eingesetzt, in denen der Alkoholrest linear oder bevorzugt in 2-Stellung methylverzweigt sein kann bzw. lineare und methylverzweigte Reste im Gemisch enthalten kann, so wie sie üblicherweise in Oxoalkoholresten vorliegen. Insbesondere sind jedoch Alkoholethoxylate mit linearen Resten aus Alkoholen nativen Ursprungs mit 12 bis 18 C-Atomen, zum Beispiel aus Kokos-, Palm-, Talgfett- oder Oleylalkohol, und durchschnittlich 2 bis 8 EO pro Mol Alkohol bevorzugt. Zu den bevorzugten ethoxylierten Alkoholen gehören beispielsweise C12-C14-Alkohole mit 3 EO, 4 EO oder 7 EO, C9-C11-Alkohol mit 7 EO, C13-C15- Alkohole mit 3 EO, 5 EO, 7 EO oder 8 EO, C12-C18-Alkohole mit 3 EO, 5 EO oder 7 EO und Mischungen aus diesen, wie Mischungen aus C12-C14-Alkohol mit 3 EO und C12-C18-Alkohol mit 7 EO. Die angegebenen Ethoxylierungsgrade stellen statistische Mittelwerte dar, die für ein spezielles Produkt eine ganze oder eine gebrochene Zahl sein können. Bevorzugte Alkoholethoxylate weisen eine eingeengte Homologenverteilung auf. Zusätzlich zu diesen nichtionischen Tensiden können auch Fettalkohole mit mehr als 12 EO eingesetzt werden. Beispiele hierfür sind Talgfettalkohol mit 14 EO, 25 EO, 30 EO oder 40 EO. Auch nichtionische Tenside, die EO- und PO(Propylenoxid)-Gruppen zusammen im Molekül enthalten, sind einsetzbar. Hierbei können Blockcopolymere mit EO-PO-Blockeinheiten bzw. PO-EO-Blockeinheiten eingesetzt werden, aber auch EO-PO-EO-Copolymere bzw. PO-EO-PO-Copolymere.
Selbstverständlich sind auch gemischt alkoxylierte nichtionische Tenside einsetzbar, in denen EO-und PO-Einheiten nicht blockweise, sondern statistisch verteilt sind. Solche Produkte sind durch gleichzeitige Einwirkung von Ethylen- und Propylenoxid auf Fettalkohole erhältlich.
Außerdem können als weitere nichtionische Tenside auch Alkylglykoside eingesetzt werden.
Eine weitere Klasse bevorzugt eingesetzter nichtionischer Tenside, die entweder als alleiniges nichtionisches Tensid oder in Kombination mit anderen nichtionischen Tensiden eingesetzt werden, sind alkoxylierte, vorzugsweise ethoxylierte oder ethoxylierte und propoxylierte Fettsaurealkylester, vorzugsweise mit 1 bis 4 Kohlenstoffatomen in der Alkylkette, insbesondere Fettsäuremethylester, wie sie beispielsweise in der japanischen Patentanmeldung JP 58/217598 beschrieben sind oder die vorzugsweise nach dem in der internationalen Patentanmeldung WO-A-90/13533 beschriebenen Verfahren hergestellt werden.
Auch nichtionische Tenside vom Typ der Aminoxide, beispielsweise N-Kokosalkyl-N,N-dimethylaminoxid und N-Talgalkyl-N,N-dihydroxyethylaminoxid, und der Fettsäurealkanolamide können geeignet sein. Die Menge dieser nichtionischen Tenside beträgt vorzugsweise nicht mehr als die der ethoxylierten Fettalkohole, insbesondere nicht mehr als die Hälfte davon.
Weitere geeignete Tenside sind Polyhydroxyfettsäureamide; bei den Polyhydroxyfettsäureamiden handelt es sich um Stoffe, die üblicherweise durch reduktive Aminierung eines reduzierenden Zuckers mit Ammoniak, einem Alkylamin oder einem Alkanolamin und nachfolgende Acylierung mit einer Fettsäure, einem Fettsäurealkylester oder einem Fettsäurechlorid erhalten werden können.
The nonionic surfactants used are preferably alkoxylated, advantageously ethoxylated, in particular primary, alcohols having preferably 8 to 18 carbon atoms and on average 1 to 12 moles of ethylene oxide (EO) per mole of alcohol, in which the alcohol radical can be linear or preferably methyl-branched in the 2-position or linear and methyl-branched radicals in the mixture can contain, as they are usually present in Oxoalkoholresten. In particular, however, alcohol ethoxylates with linear radicals of alcohols of native origin having 12 to 18 carbon atoms, for example of coconut, palm, tallow or oleyl alcohol, and on average 2 to 8 EO per mole of alcohol are preferred. The preferred ethoxylated alcohols include, for example, C12-C14 alcohols with 3 EO, 4 EO or 7 EO, C9-C11 alcohol with 7 EO, C13-C15 alcohols with 3 EO, 5 EO, 7 EO or 8 EO, C12 C18 alcohols with 3 EO, 5 EO or 7 EO and mixtures of these, such as mixtures of C12-C14 alcohol with 3 EO and C12-C18 alcohol with 7 EO. The degrees of ethoxylation given represent statistical means which, for a particular product, may be an integer or a fractional number. Preferred alcohol ethoxylates have a narrow homolog distribution. In addition to these nonionic surfactants, fatty alcohols with more than 12 EO can also be used. Examples include tallow fatty alcohol with 14 EO, 25 EO, 30 EO or 40 EO. Nonionic surfactants containing EO and PO (propylene oxide) groups together in the molecule can also be used. Here, block copolymers with EO-PO block units or PO-EO block units can be used, but also EO-PO-EO copolymers or PO-EO-PO copolymers.
Of course, it is also possible to use mixed alkoxylated nonionic surfactants in which EO and PO units are not distributed in blocks, but randomly. Such products are available by the simultaneous action of ethylene and propylene oxide on fatty alcohols.
In addition, alkyl glycosides can also be used as further nonionic surfactants.
Another class of preferred nonionic surfactants used either as the sole nonionic surfactant or in combination with other nonionic surfactants Surfactants are alkoxylated, preferably ethoxylated or ethoxylated and propoxylated Fettsaurealkylester, preferably having 1 to 4 carbon atoms in the alkyl chain, in particular fatty acid methyl esters, as described for example in Japanese Patent Application JP 58/217598 are described or preferably according to the in the international patent application WO 90/13533 be prepared described methods.
Nonionic surfactants of the amine oxide type, for example N-cocoalkyl-N, N-dimethylamine oxide and N-tallowalkyl-N, N-dihydroxyethylamine oxide, and the fatty acid alkanolamides may also be suitable. The amount of these nonionic surfactants is preferably not more than that of the ethoxylated fatty alcohols, especially not more than half thereof.
Further suitable surfactants are polyhydroxy fatty acid amides; the polyhydroxy fatty acid amides are substances which can usually be obtained by reductive amination of a reducing sugar with ammonia, an alkylamine or an alkanolamine and subsequent acylation with a fatty acid, a fatty acid alkyl ester or a fatty acid chloride.

Der Gehalt an nichtionischen Tensiden beträgt in den erfindungsgemäßen Formulierungen bevorzugt 5 bis 30 Gew.-%, vorzugsweise 7 bis 20 Gew.-% und insbesondere 9 bis 15 Gew.-%, jeweils bezogen auf die gesamte Formulierung.The content of nonionic surfactants in the formulations according to the invention is preferably 5 to 30% by weight, preferably 7 to 20% by weight and in particular 9 to 15% by weight, based in each case on the entire formulation.

Als anionische Tenside werden beispielsweise solche vom Typ der Sulfonate und Sulfate eingesetzt. Als Tenside vom Sulfonat-Typ kommen dabei vorzugsweise C9-C13-Alkylbenzolsulfonate, Olefinsulfonate, d.h. Gemische aus Alken- und Hydroxyalkansulfonaten sowie Disulfonaten, wie man sie beispielsweise aus C12-C18-Monoolefinen mit end- oder innenständiger Doppelbindung durch Sulfonieren mit gasförmigem Schwefeltrioxid und anschließende alkalische oder saure Hydrolyse der Sulfonierungsprodukte erhält, in Betracht. Geeignet sind auch Alkansulfonate, die aus C12-C18-Alkanen beispielsweise durch Sulfochlorierung oder Sulfoxidation mit anschließender Hydrolyse bzw. Neutralisation gewonnen werden. Ebenso sind auch die Ester von α -Sulfofettsäuren (Estersulfonate), zum Beispiel die α-sulfonierten Methylester der hydrierten Kokos-, Palmkern- oder Talgfettsäuren geeignet.
Weitere geeignete anionische Tenside sind sulfierte Fettsäureglycerinester. Unter Fettsäureglycerinestern sind die Mono-, Di- und Triester sowie deren Gemische zu verstehen, wie sie bei der Herstellung durch Veresterung von einem Monoglycerin mit 1 bis 3 Mol Fettsäure oder bei der Umesterung von Triglyceriden mit 0,3 bis 2 Mol Glycerin erhalten werden. Bevorzugte sulfierte Fettsäureglycerinester sind dabei die Sulfierprodukte von gesättigten Fettsäuren mit 6 bis 22 Kohlenstoffatomen, beispielsweise der Capronsäure, Caprylsäure, Caprinsäure, Myristinsäure, Laurinsäure, Palmitinsäure, Stearinsäure oder Behensäure.
Als Alk(en)ylsulfate werden die Alkali- und insbesondere die Natriumsalze der Schwefelsäurehalbester der C12-C18-Fettalkohole, beispielsweise aus Kokosfettalkohol, Talgfettalkohol, Lauryl-, Myristyl-, Cetyl- oder Stearylalkohol oder der C10-C20-Oxoalkohole und diejenigen Halbester sekundärer Alkohole dieser Kettenlängen bevorzugt. Weiterhin bevorzugt sind Alk(en)ylsulfate der genannten Kettenlänge, welche einen synthetischen, auf petrochemischer Basis hergestellten geradkettigen Alkylrest enthalten, die ein analoges Abbauverhalten besitzen wie die adäquaten Verbindungen auf der Basis von fettchemischen Rohstoffen. Aus waschtechnischem Interesse sind die C12-C16-Alkylsulfate und C12-C18-Alkylsulfate sowie C14-C18-Alkylsulfate bevorzugt. Auch 2,3-Alkylsulfate, welche beispielsweise gemäß den US-Patentschriften 3,234,258 oder 5,075,041 hergestellt werden und als Handelsprodukte der Shell Oil Company unter dem Namen DAN® erhalten werden können, sind geeignete anionische Tenside.
Auch die Schwefelsäuremonoester der mit 1 bis 6 Mol Ethylenoxid ethoxylierten geradkettigen oder verzweigten C7-C20-Alkohole, wie 2-Methyl-verzweigte C9-C11-Alkohole mit im Durchschnitt 3,5 Mol Ethylenoxid (EO) oder C12-C18-Fettalkohole mit 1 bis 4 EO, sind geeignet. Sie werden in Reinigungsmitteln aufgrund ihres hohen Schaumverhaltens nur in relativ geringen Mengen, beispielsweise in Mengen von 1 bis 5 Gew.-%, eingesetzt.
Weitere geeignete anionische Tenside sind auch die Salze der Alkylsulfobernsteinsäure, die auch als Sulfosuccinate oder als Sulfobernsteinsäureester bezeichnet werden und die Monoester und/oder Diester der Sulfobernsteinsäure mit Alkoholen, vorzugsweise Fettalkoholen und insbesondere ethoxylierten Fettalkoholen darstellen. Bevorzugte Sulfosuccinate enthalten C8-C18-Fettalkoholreste oder Mischungen aus diesen. Insbesondere bevorzugte Sulfosuccinate enthalten einen Fettalkoholrest, der sich von ethoxylierten Fettalkoholen ableitet. Dabei sind wiederum Sulfosuccinate, deren Fettalkohol-Reste sich von ethoxylierten Fettalkoholen mit enger Homologenverteilung ableiten, besonders bevorzugt. Ebenso ist es auch möglich, Alk(en)ylbernsteinsäure mit vorzugsweise 8 bis 18 Kohlenstoffatomen in der Alk(en)ylkette oder deren Salze einzusetzen. Insbesondere bevorzugte anionische Tenside sind Seifen. Geeignet sind gesättigte und ungesättigte Fettsäureseifen, wie die Salze der Laurinsäure, Myristinsäure, Palmitinsäure, Stearinsäure, (hydrierten) Erucasäure und Behensäure sowie insbesondere aus natürlichen Fettsäuren, zum Beispiel Kokos-, Palmkern-, Olivenöl- oder Talgfettsäuren, abgeleitete Seifengemische.
Die anionischen Tenside einschließlich der Seifen können in Form ihrer Natrium-, Kalium- oder Ammoniumsalze sowie als lösliche Salze organischer Basen, wie Mono-, Di- oder Triethanolamin, vorliegen. Vorzugsweise liegen die anionischen Tenside in Form ihrer Natrium- oder Kaliumsalze, insbesondere in Form der Natriumsalze vor.
As anionic surfactants, for example, those of the sulfonate type and sulfates are used. As surfactants of the sulfonate type are preferably C9-C13-alkylbenzenesulfonates, olefinsulfonates, ie mixtures of alkene and hydroxyalkanesulfonates and disulfonates, such as those of C12-C18 monoolefins with terminal or internal double bond by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acid hydrolysis of the sulfonation obtained. Also suitable are alkanesulfonates which are obtained from C 12 -C 18 alkanes, for example by sulfochlorination or sulfoxidation with subsequent hydrolysis or neutralization. Also suitable are the esters of α-sulfo fatty acids (ester sulfonates), for example the α-sulfonated methyl esters of hydrogenated coconut, palm kernel or tallow fatty acids.
Further suitable anionic surfactants are sulfated fatty acid glycerol esters. Fatty acid glycerol esters are to be understood as meaning the mono-, di- and triesters and mixtures thereof, as in the preparation by esterification of a monoglycerol with 1 to 3 mol fatty acid or in the transesterification of triglycerides with 0.3 to 2 mol Glycerol can be obtained. Preferred sulfated fatty acid glycerol esters are the sulfonation products of saturated fatty acids having 6 to 22 carbon atoms, for example caproic acid, caprylic acid, capric acid, myristic acid, lauric acid, palmitic acid, stearic acid or behenic acid.
Alk (en) ylsulfates are the alkali metal salts and in particular the sodium salts of the sulfuric monoesters of C12-C18 fatty alcohols, for example coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl, cetyl or stearyl alcohol or the C10-C20 oxo alcohols and those half esters secondary Alcohols of these chain lengths are preferred. Also preferred are alk (en) ylsulfates of said chain length, which contain a synthetic, produced on a petrochemical basis straight-chain alkyl radical, which have an analogous degradation behavior as the adequate compounds based on oleochemical raw materials. Of washing technology interest, the C12-C16 alkyl sulfates and C12-C18 alkyl sulfates and C14-C18 alkyl sulfates are preferred. Also 2,3-alkyl sulfates, which, for example, according to the U.S. Patents 3,234,258 or 5,075,041 and can be obtained as commercial products of the Shell Oil Company under the name DAN®, are suitable anionic surfactants.
Also, the sulfuric monoesters of ethoxylated with 1 to 6 moles of ethylene oxide straight or branched C7-C20 alcohols, such as 2-methyl-branched C9-C11 alcohols having an average of 3.5 moles of ethylene oxide (EO) or C12-C18 fatty alcohols with 1 up to 4 EO, are suitable. Due to their high foaming behavior, they are only used in detergents in relatively small amounts, for example in amounts of from 1 to 5% by weight.
Further suitable anionic surfactants are also the salts of alkylsulfosuccinic acid, which are also referred to as sulfosuccinates or as sulfosuccinic esters and the monoesters and / or diesters of sulfosuccinic acid with alcohols, preferably fatty alcohols and in particular ethoxylated fatty alcohols. Preferred sulfosuccinates contain C8-C18 fatty alcohol residues or mixtures of these. Particularly preferred sulfosuccinates contain a fatty alcohol residue derived from ethoxylated fatty alcohols. Sulfosuccinates, whose fatty alcohol residues are derived from ethoxylated fatty alcohols with a narrow homolog distribution, are again particularly preferred. Likewise, it is also possible to use alk (en) ylsuccinic acid having preferably 8 to 18 carbon atoms in the alk (en) yl chain or salts thereof. Particularly preferred anionic surfactants are soaps. Suitable are saturated and unsaturated fatty acid soaps, such as the salts of lauric acid, myristic acid, Palmitic acid, stearic acid, (hydrogenated) erucic acid and behenic acid, and in particular soap mixtures derived from natural fatty acids, for example coconut, palm kernel, olive oil or tallow fatty acids.
The anionic surfactants including the soaps may be in the form of their sodium, potassium or ammonium salts and as soluble salts of organic bases such as mono-, di- or triethanolamine. The anionic surfactants are preferably present in the form of their sodium or potassium salts, in particular in the form of the sodium salts.

Der Gehalt an anionischen Tensiden der erfindungsgemäßen Formulierung beträgt vorzugsweise 2 bis 30 Gew.-%, vorzugsweise 4 bis 25 Gew.-% und insbesondere 5 bis 22 Gew.-% bezogen auf die gesamte Formulierung.The content of anionic surfactants of the formulation according to the invention is preferably 2 to 30 wt .-%, preferably 4 to 25 wt .-% and in particular 5 to 22 wt .-% based on the total formulation.

Als amhpotere Tenside können erfindungsgemäß solche oberflächenaktiven Verbindungen eingesetzt werden, die im Molekül mindestens eine quartäre Ammoniumgruppe und mindestens eine -COO-- oder -SO3 - -Gruppe tragen. Besonders bevorzugte amphotere Tenside sind in diesem Zusammenhang Betain-Tenside wie Alkyl- oder Alkylamidopropylbetaine. Insbesondere sind hier Betaine wie die N-Alkyl-N,N-dimethylammonium-glycinate, z. B. das Kokosalkyl-dimethylammoniumglycinat, N-Acyl-aminopropyl-N,N-dimethylammoniumglycinate, z. B. das Kokosacylaminopropyldimethylammoniumglycinat, das C12-C18-Alkyl-dimethyl-acetobetain, das Kokosamidopropyl-dimethyl-acetobetain, 2-Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazoline und Sulfobetaine mit jeweils 8 bis 18 C-Atomen in der Alkyl- oder Acylgruppe sowie das Kokosacylaminoethylhydroxyethylcarboxymethylglycinat bevorzugt. Ein besonders bevorzugtes zwitterionisches Tensid ist das unter der INCI-Bezeichnung Cocamidopropyl Betaine bekannte N,N-Dimethyl-N-(lauroylamidopropyl)ammoniumacetobetain.
Weitere geeignete amphotere Tenside bildet die Gruppe der Amphoacetate und Amphodiacetate, insbesondere beispielsweise Kokos- oder Laurylamphoacetate oderdiacetate, die Gruppe der Amphopropionate und Amphodipropionate sowie die Gruppe der aminosäurebasierten Tenside wie Acylglutamate, insbesondere Disodium Cocoyl Glutamate und Sodium Cocoyl Glutamate, Acylglycinate, insbesondere Cocoyl Glycinate, und Acylsarcosinate, insbesondere Ammonium Lauroyl Sarcosinate und Sodium Cocoyl Sarcosinate.
According to the invention, such surface-active compounds which carry at least one quaternary ammonium group and at least one -COO-- or -SO 3 - group in the molecule can be used as amphoteric surfactants. Particularly preferred amphoteric surfactants in this context are betaine surfactants such as alkyl or alkylamidopropyl betaines. In particular, here are betaines such as the N-alkyl-N, N-dimethylammonium glycinate, z. As the cocoalkyl dimethylammoniumglycinat, N-acyl-aminopropyl-N, N-dimethylammoniumglycinate, z. Cocoacylaminopropyldimethylammonium glycinate, C12-C18-alkyl-dimethyl-acetobetaine, cocoamidopropyl-dimethyl-acetobetaine, 2-alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines and sulfobetaines each having 8 to 18 carbon atoms in the alkyl or acyl group, as well as cocoacylaminoethylhydroxyethylcarboxymethylglycinate. A particularly preferred zwitterionic surfactant is the N, N-dimethyl-N- (lauroylamidopropyl) ammonium acetobetaine known by the INCI name Cocamidopropyl Betaine.
Further suitable amphoteric surfactants are the group of amphoacetates and amphodiacetates, in particular coconut or laurylamphoacetates or diacetates, the group of amphopropionates and amphodipropionates and the group of amino acid-based surfactants such as acylglutamates, in particular disodium cocoyl glutamates and sodium cocoyl glutamates, acylglycinates, in particular cocoyl glycinates, and acyl sarcosinates, especially ammonium lauroyl sarcosinates and sodium cocoyl sarcosinates.

Besonders bevorzugte erfindungsgemäße Waschmittelformulierungen sind dadurch gekennzeichnet, dass das Tensid ausgewählt ist aus der Gruppe der Sulfonate und Sulfate, bevorzugt der linearen Alkyl-Benzol-Sulfonate, insbesondere aus der Gruppe der C9 - C13 Alkyl-Benzol-Sulfonate, ganz besonders bevorzugt Natrium-(n-C10-C13)-Alkyl-Benzol-Sulfonat.Particularly preferred detergent formulations according to the invention are characterized in that the surfactant is selected from the group of sulfonates and Sulfates, preferably of the linear alkyl-benzene sulfonates, in particular from the group of C 9 - C 13 alkyl benzene sulfonates, most preferably sodium (nC 10 -C 13 ) alkyl benzene sulfonate.

Zusätzlich zu den Tensiden können die Waschmittelformulierungen weitere Inhaltsstoffe enthalten, die die anwendungstechnischen und/oder ästhetischen Eigenschaften der Waschmittelformulierung weiter verbessern. Im Rahmen der vorliegenden Erfindung enthalten bevorzugte Waschmittelformulierungen zusätzlich einen oder mehrere Stoffe aus der Gruppe der Gerüststoffe, Bleichmittel, Bleichaktivatoren, Enzyme, Parfüme, Parfümträger, Fluoreszenzmittel, Farbstoffe, Schauminhibitoren, Silikonöle, Antiredepositionsmittel, optischen Aufheller, Vergrauungsinhibitoren, Einlaufverhinderer, Knitterschutzmittel, Farbübertragungsinhibitoren, antimikrobiellen Wirkstoffe, Germizide, Fungizide, Antioxidantien, Konservierungsmittel, Korrosionsinhibitoren, Antistatika, Bittermittel, Bügelhilfsmittel, Phobier- und Imprägniermittel, Quell-und Schiebefestmittel, neutrale Füllsalze sowie UV-Absorber.In addition to the surfactants, the detergent formulations may contain other ingredients which further enhance the performance and / or aesthetics of the detergent formulation. In the context of the present invention, preferred detergent formulations additionally contain one or more substances from the group of builders, bleaches, bleach activators, enzymes, perfumes, perfume carriers, fluorescers, dyes, foam inhibitors, silicone oils, antiredeposition agents, optical brighteners, grayness inhibitors, anti-shrinkage agents, anti-crease agents, dye transfer inhibitors, antimicrobial agents, germicides, fungicides, antioxidants, preservatives, corrosion inhibitors, antistatic agents, bittering agents, ironing auxiliaries, repellents and impregnating agents, swelling and anti-slip agents, neutral filler salts and UV absorbers.

Beispiele für Gerüststoffe, Builder, Bleichmittel, Bleichaktivatoren, Bleichkatalysatoren und Enzymen werden in der WO 2007/115872 , Seite 22, Zeile 7 bis Seite 25, Zeile 26 beschrieben, deren diesbezüglicher expliziter Offenbarungsgehalt durch diese Bezugnahme Teil dieser Offenbarung wird. Antiredepositionsmittel, optischen Aufheller, Vergrauungsinhibitoren, Farbübertragungsinhibitoren werden beispielhaft in der WO 2007/115872 auf Seite 26, Zeile 15 bis Seite 28, Zeile 2 beschrieben, deren diesbezüglicher expliziter Offenbarungsgehalt durch diese Bezugnahme Teil dieser Offenbarung wird. Beispiele von Knitterschutzmittel, antimikrobiellen Wirkstoffe, Germizide, Fungizide, Antioxidantien, Konservierungs-mittel, Antistatika, Bügelhilfsmittel, UV-Absorber werden in der WO 2007/115872 auf den Seiten 28, Zeile 14 bis Seite 30, Zeile 22 beispielhaft beschrieben, deren diesbezüglicher expliziter Offenbarungsgehalt durch diese Bezugnahme Teil dieser Offenbarung wird.Examples of builders, builders, bleaches, bleach activators, bleach catalysts, and enzymes are disclosed in U.S. Pat WO 2007/115872 , Page 22, line 7 to page 25, line 26, the explicit disclosure of which is incorporated herein by reference. Anti redeposition agents, optical brighteners, grayness inhibitors, color transfer inhibitors are exemplified in U.S. Pat WO 2007/115872 on page 26, line 15 to page 28, line 2, the explicit disclosure of which is incorporated herein by reference. Examples of anti-wrinkling agents, antimicrobial agents, germicides, fungicides, antioxidants, preservatives, antistatic agents, ironing aids, UV absorbers are disclosed in US Pat WO 2007/115872 on page 28, line 14 to page 30, line 22 described by way of example, the explicit disclosure of which is incorporated by reference into this disclosure.

Insbesondere können die Waschmittelformulierungen zwischen 0,001 und 90, besonders bevorzugt 0,01 bis 45 Gew.-% eines oder mehrerer der hier genannten weiteren Inhaltsstoffe enthalten, wobei sich die Gew.-% auf die gesamte Waschmittelformulierung beziehen.In particular, the detergent formulations may contain between 0.001 and 90, more preferably 0.01 to 45 wt .-% of one or more of the other ingredients mentioned herein, wherein the wt .-% refer to the total detergent formulation.

Die erfindungsgemäßen Waschmittelformulierungen lassen sich vorteilhaft zur Beschleunigung von Schaumentstehung und/oder zur Schaumstabilisierung verwenden. Bevorzugt werden die erfindungsgemäßen Waschmittelformulierungen zur Schaumstabilisierung verwendet, wobei diese erfindungsgemäße Verwendung insbesondere in Gegenwart von Schmutz durchgeführt wird.The detergent formulations according to the invention can advantageously be used to accelerate foam formation and / or foam stabilization. The detergent formulations according to the invention are preferred for Foam stabilization used, this inventive use is carried out in particular in the presence of dirt.

Im Rahmen der vorgenannten erfindungsgemäßen Verwendung zur Beschleunigung von Schaumentstehung und/oder zur Schaumstabilisierung werden bevorzugt die Waschmittelformulierungen verwendet, die oben als bevorzugte Waschmittelformulierungen genannt sind.In the context of the abovementioned use according to the invention for accelerating foam formation and / or for foam stabilization, preference is given to using the detergent formulations which are mentioned above as preferred detergent formulations.

Ebenfalls Gegenstand der vorliegenden Erfindung ist die Verwendung der in den erfindungsgemäßen Waschmittelformulierungen enthaltenen Rhamnolipid-Mischungszusammensetzungen zur Beschleunigung von Schaumentstehung und/oder zur Schaumstabilisierung. Die in den erfindungsgemäßen Waschmittelformulierungen enthaltenen Rhamnolipid-Mischungszusammensetzungen werden zur Schaumstabilisierung verwendet, wobei diese erfindungsgemäße Verwendung insbesondere in Gegenwart von Schmutz durchgeführt wird.Likewise provided by the present invention is the use of the rhamnolipid mixture compositions contained in the detergent formulations according to the invention for accelerating foam formation and / or for foam stabilization. The rhamnolipid blend compositions contained in the detergent formulations according to the invention are used for foam stabilization, this use according to the invention being carried out in particular in the presence of dirt.

Im Rahmen der vorgenannten erfindungsgemäßen Verwendung zur Beschleunigung von Schaumentstehung und/oder zur Schaumstabilisierung werden bevorzugt die Rhamnolipid-Mischungszusammensetzungen verwendet, die in den oben als bevorzugt genannten Waschmittelformulierungen enthalten sind.Within the scope of the abovementioned use according to the invention for accelerating foam formation and / or for foam stabilization, preference is given to using the rhamnolipid mixture compositions which are present in the detergent formulations mentioned above as being preferred.

Ein weiterer Gegenstand der vorliegenden Erfindung ist die Verwendung einer erfindungsgemäßen Waschmittelformulierung zur Verhinderung der Vergrauung eines Textils und/oder als Antiredepositionsmittel.Another object of the present invention is the use of a detergent formulation according to the invention for preventing the graying of a textile and / or as an anti-redeposition agent.

Im Rahmen der vorgenannten erfindungsgemäßen Verwendung zur Verhinderung der Vergrauung eines Textils und/oder als Antiredepositionsmittel werden bevorzugt die Waschmittelformulierungen verwendet, die oben als bevorzugte Waschmittelformulierungen genannt sind.In the context of the abovementioned use according to the invention for preventing the graying of a textile and / or as an anti-redeposition agent, preference is given to using the detergent formulations which are mentioned above as preferred detergent formulations.

Noch ein Gegenstand der vorliegenden Erfindung ist die Verwendung einer Rhamnolipid-Mischungszusammensetzung gemäß Anspruch 1 zur Verhinderung der Vergrauung eines Textils und/oder als Antiredepositionsmittel, wobei die in den erfindungsgemäßen Waschmittelformulierungen enthaltenen Rhamnolipid-Mischungszusammensetzungen verwendet werden. Besonders bevorzugt werden im Rahmen der vorgenannten erfindungsgemäßen Verwendung zur Verhinderung der Vergrauung eines Textils und/oder als Antiredepositionsmittel bevorzugt die Rhamnolipid-Mischungszusammensetzungen verwendet, die in den oben als bevorzugt genannten Waschmittelformulierungen enthalten sind.Another object of the present invention is the use of a rhamnolipid blend composition according to claim 1 for preventing the graying of a textile and / or as an anti redeposition agent, wherein the rhamnolipid blend compositions contained in the detergent formulations according to the invention are used. In the context of the abovementioned use according to the invention for preventing the graying of a textile and / or as antiredeposition agent, the rhamnolipid mixture compositions which are contained in the detergent formulations mentioned above as being preferred are particularly preferably used.

In den nachfolgend aufgeführten Beispielen wird die vorliegende Erfindung beispielhaft beschrieben, ohne dass die Erfindung, deren Anwendungsbreite sich aus der gesamten Beschreibung und den Ansprüchen ergibt, auf die in den Beispielen genannten Ausführungsformen beschränkt sein soll.In the examples given below, the present invention is described by way of example, without the invention, the scope of application of which is apparent from the entire description and the claims, to be limited to the embodiments mentioned in the examples.

Beispiele:Examples: Beispiel 1: Herstellung von Rhamnolipiden mit rhIABC aus P. aeruginosa PAO1 in P. putida, wobei die Expression des für die Rhamnosyltransferase RhIC kodierenden Gens vielfach stärker ist, als die des für die Rhamnosyltransferase RhIB kodierenden Gens rhIBExample 1: Production of rhamnolipids with rhIABC from P. aeruginosa PAO1 in P. putida, wherein the expression of the gene coding for the rhamnosyltransferase RhIC is in many cases stronger than that of the gene RhIB coding for the rhamnosyltransferase RhIB

Um Rhamnolipide mit rhIABC aus P. aeruginosa PAO1 in einem P. putida-Stamm herzustellen, in dem die Expression des für die Rhamnosyltransferase RhIC kodierenden Gens vielfach stärker erfolgt, als die des für die Rhamnosyltransferase RhIB kodierenden Gens rhIB, wird das Plasmid pBBR1 MCS2-Plac-rhIABC-T-Ptac-rhIC-T (Seq ID Nr. 1) konstruiert. Dazu wurden folgende DNA-Fragmente synthetisiert: P. aeruginosa PAO1-Gene rhIA, rhIB und rhIC, gefolgt von einem Terminator, gefolgt vom synthetischen tac-Promoter, gefolgt vom P. aeruginosa PAO1-Gene rhIC und einem Terminator, flankiert von einer HindIII- (5'-Ende) bzw. Bsu36I-Schnittstelle (3'-Ende) (Seq ID Nr. 2).In order to produce rhamnolipids with P. aeruginosa rhIABC PAO1 in a P. putida strain in which the expression of the gene coding for the rhamnosyltransferase RhIC is much stronger than that of the gene coding for the rhamnosyltransferase RhIB gene, the plasmid pBBR1 MCS2- Plac-rhIABC-T-Ptac-rhIC-T (SEQ ID NO: 1). For this, the following DNA fragments were synthesized: P. aeruginosa PAO1 genes rhIA, rhIB and rhIC, followed by a terminator, followed by the synthetic tac promoter, followed by the P. aeruginosa PAO1 gene rhIC and a terminator flanked by Hin dIII - (5 'end) or Bsu 36I interface (3' end) ( SEQ ID NO: 2).

Die vom DNA-Synthese-Provider gelieferten Vektoren, die das synthetisierte DNA Fragment enthalten, werden mit HindIII und Bsu36I geschnitten und in den ebenfalls mit HindIII und Bsu36I geschnittenen Vektor pBBR1 MCS-2 (Seq ID 3) mittels Fast Link Ligation Kit (Epicentre Technologies; Madison, WI, USA) ligiert. Der erhaltene Zielvektor pBBR1MCS2-Plac-rhIABC-T-Ptac-rhIC-T (pBBR1 MCS-2 mit synthetisiertem Fragment Seq ID Nr. 2) hat eine Größe von 9336 Basenpaaren.The vectors supplied by the DNA synthesis provider containing the synthesized DNA fragment are cleaved with Hin dIII and Bsu 36I and inserted into Hin dIII and Bsu 36I vector pBBR1 MCS-2 (Seq ID 3) by fast link ligation Kit (Epicenter Technologies, Madison, WI, USA). The obtained target vector pBBR1MCS2-Plac-rhIABC-T-Ptac-rhIC-T (pBBR1 MCS-2 with synthesized fragment Seq ID No. 2) has a size of 9336 base pairs.

Die Transformation von Pseudomonas putida KT2440 mit dem Vektor pBBR1 MCS2-Plac-rhIABC-T-Ptac-rhIC-T (Seq ID Nr. 1) erfolgt wie vorbeschrieben ( Iwasaki et al. Biosci. Biotech. Biochem. 1994. 58(5):851-854 ). Die Plasmid-DNA von je 10 Klonen wird isoliert und analysiert. Der erhaltene, das Plasmid tragende Stamm wird P. putida KT2440 pBBR1 MCS2-Plac-rhIABC-T-Ptac-rhIC-T genannt.The transformation of Pseudomonas putida KT2440 with the vector pBBR1 MCS2-Plac-rhIABC-T-Ptac-rhIC-T (Seq ID No. 1) is carried out as described above ( Iwasaki et al. Biosci. Biotech. Biochem. 1994. 58 (5): 851-854 ). The plasmid DNA of 10 clones each is isolated and analyzed. The resulting plasmid-carrying strain is called P. putida KT2440 pBBR1 MCS2-Plac-rhIABC-T-Ptac-rhIC-T.

Der rekombinante Stamm P. putida KT2440 pBBR1 MCS2-Plac-rhIABC-T-Ptac-rhIC-T wird auf LB-Agar-Kanamycin (50 µg/ml)-Platten kultiviert.Recombinant strain P. putida KT2440 pBBR1 MCS2-Plac-rhIABC-T-Ptac-rhIC-T is cultured on LB agar kanamycin (50 μg / ml) plates.

Zur Produktion der Rhamnolipide wird das im Folgenden als M9-Medium bezeichnete Medium verwendet. Dieses Medium besteht aus 2 % (w/v) Glukose, 0,3 % (w/v) KH2PO4, 0,679 % Na2HPO4, 0,05 % (w/v) NaCl, 0,2 % (w/v) NH4Cl, 0,049 % (w/v) MgSO4 x 7 H2O und 0,1 % (v/v) einer Spurenelementlösung. Diese besteht aus 1,78 % (w/v) FeSO4 x 7 H2O, 0,191 % (w/v) MnCl2 x 7 H2O, 3,65 % (w/v) HCl, 0,187 % (w/v) ZnSO4 x 7 H2O, 0,084 % (v/v) Na-EDTA x 2 H2O, 0,03 % (v/v) H3BO3, 0,025 % (w/v) Na2MoO4 x 2 H2O und 0,47 % (w/v) CaCl2 x 2 H2O. Der pH-Wert des Mediums wird mit NH4OH auf 7,4 eingestellt und das Medium folgend mittels Autoklav (121 °C, 20 min) sterilisiert. Ein Einstellen des pH-Wertes während der Kultivierung ist nicht nötig.For the production of rhamnolipids, the medium referred to below as M9 medium is used. This medium consists of 2% (w / v) glucose, 0.3% (w / v) KH 2 PO 4 , 0.679% Na 2 HPO 4 , 0.05% (w / v) NaCl, 0.2% ( w / v) NH 4 Cl, 0.049% (w / v) MgSO 4 x 7 H 2 O and 0.1% (v / v) of a trace element solution. This consists of 1.78% (w / v) FeSO 4 .7H 2 O, 0.191% (w / v) MnCl 2 .7H 2 O, 3.65% (w / v) HCl, 0.187% (w / v) / v) ZnSO 4 .7H 2 O, 0.084% (v / v) Na-EDTA x 2H 2 O, 0.03% (v / v) H 3 BO 3 , 0.025% (w / v) Na 2 MoO 4 × 2 H 2 O and 0.47% (w / v) CaCl 2 × 2 H 2 O. The pH of the medium is adjusted to 7.4 with NH 4 OH and the medium is subsequently autoclave (121 ° C, 20 min). It is not necessary to adjust the pH during the cultivation.

Zur Untersuchung der Rhamnolipidproduktion im Schüttelkolben wird zunächst eine Vorkultur angesetzt. Hierzu wird eine Kolonie eines frisch auf LB-Agar-Platte ausgestrichenen Stammes verwendet und 10 ml LB-Medium in einem 100 ml Erlenmeyerkolben beimpft. Alle rekombinanten P. putida-Stämme werden im LB-Medium, dem 50 µg/ml Kanamycin zugesetzt wird, kultiviert. Die Kultivierung der P. putida-Stämme erfolgt bei 30 °C und 200 rpm über Nacht.To study the production of rhamnolipids in a shake flask, a preculture is first prepared. For this purpose, a colony of a strain freshly streaked out on an LB agar plate is used and 10 ml of LB medium are inoculated in a 100 ml Erlenmeyer flask. All recombinant P. putida strains are cultured in LB medium to which 50 μg / ml kanamycin is added. The cultivation of the P. putida strains takes place at 30 ° C. and 200 rpm overnight.

Die Vorkulturen werden verwendet, um 50 ml M9-Medium (+ 50 µg/ml Kanamycin) im 250 ml Erlenmeyerkolben zu beimpfen (Start-OD600 0,1). Die Kulturen werden bei 200 rpm und 30 °C kultiviert. Nach 24 h wird eine Probe von 1 ml Kulturbrühe dem Kulturkolben entnommen.The precultures are used to inoculate 50 ml of M9 medium (+ 50 μg / ml kanamycin) in the 250 ml Erlenmeyer flask (start OD 600 0.1). The cultures are cultured at 200 rpm and 30 ° C. After 24 h, a sample of 1 ml of culture broth is removed from the culture flask.

Fermentation und AufreinigungFermentation and purification

Für die Hauptkultur kommt ebenfalls ein Mineralmedium (M9) zum Einsatz. Die Fermentation nach Animpfen mit 10 vol. % Vorkultur und Verbrauch der vorgelegten Glucose erfolgt kohlenstofflimitiert über eine Glukosezufütterung in einem 2 Liter Fermenter mit einem Arbeitsvolumen von 1,2 L . Die Glukosezufütterung erfolgt anhand des Gelöstsauerstoffsignals. Der Gelöstsauerstoff wird bei 20 % Sättigung über die Rührerdrehzahl reguliert. Der pH Wert wird über eine pH Elektrode und Zugabe von NH4SO4 auf 7 reguliert. Die Fermentation wird über 4 Tage bis zu einer Biotrockenmasse von 15 g/l geführt. Die Rhamnolipidkonzentration wird über HPLC ermittelt und beträgt 9,8 g/l. Nach Abtrennen der Zellen mittels Zentrifugation bei 10.000 g wird die Fermentationsbrühe durch Zugabe konzentrierter HCl auf einen pH-Wert von 4,0 eingestellt. Anschließend wird mit gleichem Volumen Ethylacetat extrahiert. Die rhamnolipidhaltige organische Phase wird abgetrennt und weiter verarbeitet. Durch Zugabe von 50 Gew %iger KOH (aq) wird der pH-Wert der Lösung auf pH 7 eingestellt. Hierbei kommt es zur Bildung zweier flüssiger Phasen. Die untere Phase enthält die von lipophilen und hydrophilen Verunreinigungen befreiten Rhamnolipide in hoher Reinheit. Die Zusammensetzung der Rhamnolipid-Mischung wird hierdurch nicht beeinflusst. Die untere Phase wird abgenommen und das Lösungsmittel am Rotationsverdampfer weitestgehend entfernt. Dann wird erneut Wasser zugegeben und die wässrige Rhamnolipid Lösung gefriergetrocknet. Das erhaltene Pulver wird mittels HPLC analysiert und anwendungstechnisch charakterisiert.For the main culture also a mineral medium (M9) is used. The fermentation after inoculation with 10 vol. % Pre-culture and consumption of the glucose is carbon-limited by means of a glucose feed in a 2 liter fermenter with a working volume of 1.2 l. The glucose feed is based on the dissolved oxygen signal. The dissolved oxygen is regulated at 20% saturation above the stirrer speed. The pH is adjusted to 7 via a pH electrode and addition of NH 4 SO 4 . The fermentation is carried out over 4 days to a dry biomass of 15 g / l. The rhamnolipid concentration is determined by HPLC and is 9.8 g / l. After separating the cells by centrifugation at 10,000 g, the fermentation broth is adjusted to a pH of 4.0 by adding concentrated HCl. The mixture is then extracted with the same volume of ethyl acetate. The rhamnolipidhaltige organic phase is separated and on processed. By adding 50% strength by weight KOH (aq), the pH of the solution is adjusted to pH 7. This leads to the formation of two liquid phases. The lower phase contains the liberated from lipophilic and hydrophilic impurities rhamnolipids in high purity. The composition of the rhamnolipid mixture is not affected by this. The lower phase is removed and the solvent removed as far as possible on a rotary evaporator. Then water is added again and the aqueous rhamnolipid solution is freeze-dried. The resulting powder is analyzed by means of HPLC and characterized by application technology.

Quantifizierung von RhamnolipidenQuantification of rhamnolipids

Die Probenvorbereitung für die nachfolgenden chromatographischen Analysen erfolgt folgendermaßen Mit einer Verdrängerpipette (Combitip) wird in einem 2 ml-Reaktionsgefäß 1 ml Aceton vorgelegt und das Reaktionsgefäß zur Minimierung von Verdunstung unmittelbar verschlossen. Es folgt die Zugabe von 1 ml Kulturbrühe. Nach Vortexen des Kulturbrühe/Acetongemisches wird dieses für 3 min bei 13.000 rpm abzentrifugiert, und 800 µl des Überstands in ein HPLC-Gefäß überführt.Sample preparation for the subsequent chromatographic analyzes is carried out as follows: 1 ml of acetone is introduced into a 2 ml reaction vessel using a displacement pipette (Combitip) and the reaction vessel is immediately closed to minimize evaporation. This is followed by the addition of 1 ml of culture broth. After vortexing the culture broth / acetone mixture, this is centrifuged off for 3 min at 13,000 rpm and 800 μl of the supernatant are transferred to an HPLC vessel.

Zum Nachweis und zur Quantifizierung von Rhamnolipiden wird ein Evaporative Light Scattering Detektor (Sedex LT-ELSD Model 85LT) benutzt. Die eigentliche Messung wird mittels Agilent Technologies 1200 Series (Santa Clara, Kalifornien) und der Zorbax SB-C8 Rapid Resolution Säule (4,6 x 150 mm, 3,5 µm, Agilent) durchgeführt. Das Injektionsvolumen beträgt 5 µl und die Laufzeit der Methode 20 min. Als mobile Phase wird wässrige 0,1 % TFA (Trifluor-Essigsäure, Lösung A) und Methanol (Lösung B) verwendet. Die Säulentemperatur beträgt 40 °C. Als Detektoren dienen der ELSD (Detektortemperatur 60 °C) und der DAD (Diodenarray, 210 nm). Der in der Methode verwendete Gradient ist: t [min] Lösung B vol.-% Fluss [ml/min] 0,00 70% 1,00 15,00 100% 1,00 15,01 70% 1,00 20,00 70% 1,00 An Evaporative Light Scattering Detector (Sedex LT-ELSD Model 85LT) is used to detect and quantify rhamnolipids. The actual measurement is performed using Agilent Technologies 1200 Series (Santa Clara, California) and the Zorbax SB-C8 Rapid Resolution column (4.6 x 150 mm, 3.5 μm, Agilent). The injection volume is 5 μl and the runtime of the method is 20 min. The mobile phase used is aqueous 0.1% TFA (trifluoroacetic acid, solution A) and methanol (solution B). The column temperature is 40 ° C. The detectors used are the ELSD (detector temperature 60 ° C) and the DAD (diode array, 210 nm). The gradient used in the method is: t [min] Solution B vol .-% Flow [ml / min] 0.00 70% 1.00 15.00 100% 1.00 15,01 70% 1.00 20.00 70% 1.00

Die mit oben beschriebenem Verfahren erhaltene Rhamnolipidzusammensetzung aus P. putida KT2440 pBBR1MCS2-Plac-rhIABC-T-Ptac-rhIC-T enthält: diRL-C10C10 81 Gew.-% diRL-C10C12 10 Gew.-% diRL-C10C12:1 8 Gew.-% monoRL-C10C10 1 Gew.-% woraus ein Gewichtsverhältnis von di-Rhamnolipiden zu mono-Rhamnolipiden von 99:1 resultiert.The rhamnolipid composition of P. putida KT2440 pBBR1MCS2-Plac-rhIABC-T-Ptac-rhIC-T obtained by the method described above contains: DIRL-C10C10 81% by weight DIRL-C10C12 10% by weight DIRL-C10C12: 1 8% by weight monoRL-C10C10 1% by weight resulting in a weight ratio of di-rhamnolipids to mono-rhamnolipids of 99: 1 results.

Beispiel 2: Anwendungstechnische Austestung - Beschreibung der Methode:Example 2: Application Testing - Description of the Method:

Das Rührwerk mit einer Halterung für 4 verschließbare Zylinder mit einem Volumen von 300 ml wird im Winkel von 90° platziert. Die 300 ml Messzylinder mit Verschluss sind so angeordnet, dass die Drehung der Zylinder horizontal erfolgt. Vor der eigentlichen Messung werden die Messzylinder mit der Tensidlösung benetzt. Diese Lösung wird anschließend verworfen.The stirrer with a holder for 4 closable cylinders with a volume of 300 ml is placed at an angle of 90 °. The 300 ml measuring cylinder with closure are arranged so that the rotation of the cylinder is horizontal. Before the actual measurement, the measuring cylinders are wetted with the surfactant solution. This solution is then discarded.

In jeden Messzylinder werden möglichst schaumfrei je 60 ml zu prüfende Tensidlösung eingefüllt. Die verschlossenen Messzylinder werden in den entsprechenden Halterungen befestigt und das Mischgerät mit 20 U/min gestartet. Zeitgleich wird eine Stoppuhr betätigt. Um die Schaumhöhen in Abhängigkeit der Zeit zu messen wird nach entsprechenden Zeitabständen das Mischwerk angehalten, 30 Sekunden gewartet, und die Schaumhöhe notiert.60 ml of surfactant solution to be tested are filled into each measuring cylinder as foam-free as possible. The sealed graduated cylinders are mounted in the appropriate holders and the mixer started at 20 rpm. At the same time a stopwatch is pressed. In order to measure the foam heights as a function of time, the mixer is stopped after appropriate time intervals, waited 30 seconds, and noted the foam height.

Soll das Schaumverhalten unter Schmutzbelastung beobachtet werden, so erfolgt die Schmutzzugabe zu definierten Zeitpunkten.If the foaming behavior is to be observed under dirt load, the dirt is added at defined times.

Die Konzentration des Tensids beträgt in allen Fällen 0,4 g Aktivsubstanz pro Liter Lösung.The concentration of the surfactant is in all cases 0.4 g of active substance per liter of solution.

Die Lösung wurde jeweils 2 min ohne Zugabe von Schmutz im Zylinder geschüttelt. Anschließend erfolgte die Zugabe der ersten Portion Schmutz, dann wurde weitere 10 min geschüttelt. Nach dem Ablesen der Schaumhöhe erfolgte die zweite Zugabe einer definierten Schmutzmenge und es wurden nochmals 10 min geschüttelt. Nach dem Ablesen der Schaumhöhe erfolgte die dritte Zugabe einer definierten Schmutzmenge und es wurde nochmals 10 min geschüttelt und die Schaumhöhe gemessen.The solution was shaken for 2 minutes without addition of dirt in the cylinder. Then the first portion of dirt was added, then shaken for a further 10 min. After reading the foam height, the second addition of a defined amount of dirt took place and it was shaken again for 10 minutes. After reading the foam height, the third addition of a defined amount of dirt took place and it was shaken again for 10 minutes and the foam height was measured.

Die gemessenen Schaumhöhen stellen Mittelwerte aus 4 Einzelmessungen dar.The measured foam heights represent mean values of 4 individual measurements.

Als Schmutz wurde Standardschmutzgewebe SBL 2004 der Firma wfk Testgewebe GmbH aus Krefeld benutzt. Die Schmutzbeladung des Gewebes beträgt 8g Schmutz pro Gewebestück (zertifiziert von der Firma wfk Testgewebe GmbH aus Krefeld). SBL 2004 ist ein weit verbreiteter Industrieschmutzstanddard, um die Waschleitung von Waschmitteln in Gegenwart von Schmutz zu untersuchen.As dirt standard dirt cloth SBL 2004 of the company wfk Testgewebe GmbH from Krefeld was used. The dirt load of the fabric is 8g of dirt per piece of fabric (certified by the company wfk Testgewebe GmbH Krefeld). SBL 2004 is a widely used industrial pollution standard to investigate the scrubbing of detergents in the presence of dirt.

Die typische Zusammensetzung des Standardschmutze ist nach Angaben der Firma wfk Testgewebe GmbH wie folgt: 18,4 % Olivenöl (Olio Extra Vergine di Oliva) 18,4 % Synthetisches Sebum nach Bey 9,4 % Kaolin 9,2 % Protein (aus Eiweißpulver) 8,0 % Bleach consuming agent 6,9 % Stärke 6,9 % Salz 6,9 % Mineralöl 6,9 % Lanolin 2,8 % Emulgator (Uniperol ® Dispergiermittel Handelsname der, BASF SE) 2,3 % Harnstoff (synthetic) 2,0 % Quartz 1,8 % Calciumchlorid 0,075 % Ruß 0,025 % Eisenoxid The typical composition of the Standardschmutze is according to the company wfk Testgewebe GmbH as follows: 18.4% Olive oil (Olio Extra Vergine di Oliva) 18.4% Synthetic Sebum after Bey 9.4% kaolin 9.2% Protein (from protein powder) 8.0% Bleach consuming agent 6.9% Strength 6.9% salt 6.9% mineral oil 6.9% lanolin 2.8% Emulsifier (Uniperol® dispersant trade name of, BASF SE) 2.3% Urea (synthetic) 2.0% Quartz 1.8% calcium chloride 0.075% soot 0.025% iron oxide

Beispiel 3: Schaumvermögen ohne SchmutzzugabeExample 3: Foaming power without dirt added Bedingungen:Conditions:

Wasserhärte: Gemessen in Grad deutscher Härte °dH, Verhältnis von Ca und Mg = 2:1 molarM
Wasser 5° dH,
0,4 g/L Aktivkonzentration an Tensid. Messwerte Schaumhöhe nach angegebener Minutenzahl: Tensid °dH 2 Min 5 Min 10 Min 15 Min 20 Min 25 Min 30 Min LAS 5 185 200 225 230 235 235 235 Bsp.1 5 162 200 227 227 227 227 227 Jeneil 5 152 198 200 200 200 200 200
Water hardness: Measured in degrees German hardness ° dH, ratio of Ca and Mg = 2: 1 molarM
Water 5 ° dH,
0.4 g / L active concentration of surfactant. Measured values of foam height after specified number of minutes: surfactant ° dH 2 min 5 min 10 minutes 15 minutes 20 min 25 min 30 min READ 5 185 200 225 230 235 235 235 Ex.1 5 162 200 227 227 227 227 227 Jeneil 5 152 198 200 200 200 200 200

Eingesetzte Tenside:Surfactants used:

LAS = MARLON ARL© der Firma Sasol, Natrium-(n-C10-C13)-alkylbenzolsulphonat mit einem Aktivgehalt von 80 Gew.-%, ist ein bekanntes, stark schäumendes Anionentensid, welches breite Verwendung in Waschmittelformulierungen findet.
Jeneil: Kommerzielle Probe mit einem hohen mono-Rhamnolipid-Anteil
LAS = MARLON ARL © Sasol, sodium (nC 10 -C 13) -alkylbenzolsulphonat with an active content of 80 wt .-%, is a known, high foaming anion surfactant, which finds wide use in detergent formulations.
Jenil: Commercial sample with a high mono-rhamnolipid content

Die Zusammensetzung des Beispiels 1 zeigt ein etwas langsameres Anschäumverhalten, erreicht aber nach 10 min ein ähnlich gutes Niveau, wie das Aniontensid LAS. Jeneil mit seinem hohen monoRL Anteil und geringem diRL Anteil zeigt ein langsameres Anschäumverhalten als Beispiel 1, welches einen geringen monoRL Anteil und einen hohen diRL Anteil aufweist, und erreicht am Ende auch nur ein deutlich kleineres Schaumniveau als LAS oder das Beispiel 1.The composition of Example 1 shows a somewhat slower foaming behavior, but reaches a similar level after 10 minutes as the anionic surfactant LAS. Each with its high monoRL content and low diRL content exhibits a slower foaming behavior than Example 1, which has a low monoRL content and a high diRL content, and finally only achieves a significantly lower foam level than LAS or Example 1.

Beispiel 4: Schaumverhalten in Gegenwart von Schmutz:Example 4 Foaming Behavior in the Presence of Dirt:

Bei dreimaliger Zugabe (vgl. Beispiel 2) von je 76 mg Schmutz in einen Zylinder zeigt die Zusammensetzung des Beispiels 1 im Vergleich zu LAS nach 15 min eine etwas höhere Schaumbildung als LAS. Nach der dritten Schmutzzugabe (nach 20 min) ist die Schaumhöhe immer noch stabil und deutlich höher als bei LAS. Die kommerzielle Probe von Jeneil zeigt bereits ohne Schmutzzugabe eine verringertes Anschäumverhalten als LAS oder die Zusammensetzung des Beispiels 1 (= Schaumhöhe bei 2 min) Messwerte Schaumhöhe nach angegebener Minutenzahl: Tensid °dH 2 Min 5 Min 10 Min 15 Min 20 Min 25 Min 30 Min LAS 5 165 20 18 9 7 4 4 Bsp.1 5 162 17 17 10 10 10 10 Jeneil 5 132 20 20 10 10 10 10 With three additions (see Example 2) of 76 mg of dirt into a cylinder, the composition of Example 1 shows a slightly higher foam formation than LAS after 15 minutes compared to LAS. After the third dirt addition (after 20 min), the foam height is still stable and significantly higher than in LAS. The commercial sample of Jeneil shows already without added dirt a reduced foaming behavior as LAS or the composition of Example 1 (= foam height at 2 min) Measured values of foam height after specified number of minutes: surfactant ° dH 2 min 5 min 10 minutes 15 minutes 20 min 25 min 30 min READ 5 165 20 18 9 7 4 4 Ex.1 5 162 17 17 10 10 10 10 Jeneil 5 132 20 20 10 10 10 10

Beispiel 5: Schaumverhalten von Mischungen von LAS und Rhamnolipiden:Example 5 Foaming Behavior of Mixtures of LAS and Rhamnolipids

Schmutzbelastung: 3 x 76 mg bei 0,4 g/L Aktivsubstanz Tensid. Es wurden Mischungen von LAS und Zusammensetzung des Beispiels 1 in den angegebenen Gewichtsverhältnissen eingesetzt. Messwerte Schaumhöhe nach angegebener Minutenzahl: Tensid °dH 2 Min 5 Min 10 Min 15 Min LAS 5 165 20 18 9 Bsp.1 5 162 17 17 10 LAS/Bsp. 1 75:25 5 167 20 18 10 LAS/Bsp. 1 50:50 5 193 34 22 12 LAS/Bsp. 1 25:75 5 182 41 25 12 Dirt load: 3 x 76 mg at 0.4 g / L active substance surfactant. Mixtures of LAS and the composition of Example 1 were used in the stated weight ratios. Measured values of foam height after specified number of minutes: surfactant ° dH 2 min 5 min 10 minutes 15 minutes READ 5 165 20 18 9 Ex.1 5 162 17 17 10 LAS / Ex. 1 75:25 5 167 20 18 10 LAS / Ex. 1 50:50 5 193 34 22 12 LAS / Ex. 1 25:75 5 182 41 25 12

Ohne Schmutzzugabe im Anschäumverhalten, d. h. im Aufbau von Schaum, zeigen Mischungen von LAS und der Zusammensetzung des Beispiels 1 eine deutlich höheres Schaumvolumen als die jeweilige Komponente alleine. Nach der ersten Schmutzzugabe (bei t = 2 min) zeigen die Mischungen von LAS und der Zusammensetzung des Beispiels 1 im Verhältnis 50:50 (w/w) und 25:75 (w/w) ein deutlich höheres Schaumvolumen und eine verstärkt Schaumstabilität als die jeweilige Komponente alleine.Without dirt added in the foaming behavior, d. H. in foam build up, blends of LAS and the composition of Example 1 show a significantly higher foam volume than the particular component alone. After the first addition of dirt (at t = 2 min), the mixtures of LAS and the composition of Example 1 in a ratio of 50:50 (w / w) and 25:75 (w / w) show a significantly higher foam volume and increased foam stability than the respective component alone.

Es konnte damit gezeigt werden, dass Mischungen von LAS und Rhamnolipiden sich im Schaumverhalten positiv synergistisch verhalten.It could thus be shown that mixtures of LAS and rhamnolipids behave positively synergistically in the foaming behavior.

Beispiel 6: WaschleistungExample 6: Washing Performance

Die Wirksamkeit der Fleckentfernung wird in einem Liniwaschgerät (Prinzip: geschlossene Metallgefäße, die in einem temperierten Wasserbad um eine horizontale Achse bewegt werden) an verschiedenen, künstlich angeschmutzten Testgeweben ermittelt. Verwendete Schmutzarten (flächig angeschmutztes Baumwollgewebe): Anschmutzung Hersteller / Lieferant Bestellnr. Soja wfk 10080 Curry wfk 10075 Ruß EMPA 114 Hautfett wfk 10013 Milch/Kakao wfk 10017 wfk = wfk Testgewebe GmbH, Krefeld
EMPA = Eidgenössische Materialprüfanstalt
The effectiveness of the stain removal is determined in a Liniwaschgerät (principle: closed metal vessels, which are moved in a tempered water bath about a horizontal axis) on various, artificially soiled test fabrics. Dirt types used (area soiled cotton fabric): soiling Manufacturer / Supplier Cat. soy wfk 10080 curry wfk 10075 soot EMPA 114 sebum wfk 10013 Milk / cocoa wfk 10017 wfk = wfk test fabric GmbH, Krefeld
EMPA = Federal Material Testing Institute

Mit einem Spektralphotometer der Marke Datacolor Elrepho SF450 mit Auswertesoftware ColorTools wird die Reflexion der Testgewebe vor und nach dem Waschen gemessen. Dabei werden unter Zuhilfenahme der CIE-Lab Farbraumklassifikation die Helligkeit L*, der Wert a* auf der rot - grün Farbachse und der Wert b* auf der gelb - blau Farbachse vor und nach dem Waschen gemessen. Die Änderung des Farbwertes (ΔE-Wert) ist dabei ein Maß für den erzielten Reinigungseffekt.With a Datacolor Elrepho SF450 spectrophotometer with ColorTools evaluation software, the reflectance of the test fabrics before and after washing is measured. The brightness L *, the value a * on the red-green color axis and the value b * on the yellow-blue color axis before and after washing are measured with the aid of the CIE-Lab color space classification. The change in the color value (ΔE value) is a measure of the achieved cleaning effect.

Der ΔE-Wert ist definiert als und wird errechnet, wobei die Errechnung automatisch über die Auswertesoftware ColorTools erfolgt, über folgende Formel Δ E = Δ a * 2 + Δ b * 2 + Δ L * 2

Figure imgb0002
d.h. je besser die Schmutzentfernung ist, desto größer wird der ΔE-Wert.The ΔE value is defined as and is calculated, the calculation being carried out automatically using the ColorTools evaluation software, using the following formula Δ e = Δ a * 2 + Δ b * 2 + Δ L * 2
Figure imgb0002
ie the better the soil removal, the larger the ΔE value becomes.

Für die Effizienz der Fleckentfernung kann folgende Einteilung verwendet werden: ΔE-Wert Beschreibung >2 Visuell feststellbarer Verringerung der Verschmutzung 4-10 Mittelmäßige Fleckentfernung 10-20 Signifikante Fleckentfernung >20 Vollständige Fleckentfernung For stain removal efficiency, the following division can be used: AE value description > 2 Visually detectable reduction of contamination 4-10 Mediocre stain removal 10-20 Significant stain removal > 20 Complete stain removal

Die Bedingungen der Waschversuche waren wie folgt: Waschflotte: Zusammensetzung vgl. Tabelle unten Wasserhärte: 16 °dH Flottenvolumen: 200 ml Waschbehälter: 500 ml Gewebebeladung pro Waschbehälter: 3 Anschmutzungen einer Sorte (10 x 10 cm) und 1 weißes Baumwollgewebe (10 x 20 cm). Die Größe der Läppchen sollte so angepasst werden, dass sie zusammen mit dem weißen Baumwollgewebe etwa 10 g wiegen. (Flottenverhältnis 1:20) Waschmechanik: 10 Stahlkugeln Ø 6 mm Waschtemperatur: 25°C Waschzeit: 30 min Spülen: 3 x 30 s mit Leitungswasser (ca. 5° dH) The conditions of the washing tests were as follows: Wash liquor: Composition cf. Table below Water hardness: 16 ° dH Fleet size: 200 ml Washing tank: 500 ml Fabric load per wash tank: 3 stains of a variety (10 x 10 cm) and 1 white cotton fabric (10 x 20 cm). The size of the lobules should be adjusted to weigh about 10g along with the white cotton fabric. (Fleet ratio 1:20) Washing mechanics: 10 steel balls Ø 6 mm Washing temperature: 25 ° C Washing time: 30 min Do the washing up: 3 x 30 s with tap water (about 5 ° dH)

Um gesicherte Messergebnisse zu erhalten, werden die Waschgänge mit jeder Waschmittelformulierung an jeder Anschmutzung 3x durchgeführt. D.h. es werden pro Waschmittelformulierung 9 Testgewebe jeder Schmutz-Sorte gewaschen. Waschmittelformulierung A: Konzentration Gew.-% (100 % aktiv Basis) Bsp.1 37,60 Glycerin 5 Propylenglykol 9 Triethanolamin 11,05 Zitronensäure 1,71 Wasser Rest In order to obtain reliable measurement results, the washes with each detergent formulation are carried out 3x at each soiling. This means that 9 test fabrics of each type of dirt are washed per detergent formulation. Detergent formulation A: Concentration% by weight (100% active base) Ex.1 37.60 glycerin 5 propylene glycol 9 triethanolamine 11.05 citric acid 1.71 water rest

Die Waschmittelformulierungen wurden mit Natronlauge auf pH 8.2 eingestellt.The detergent formulations were adjusted to pH 8.2 with sodium hydroxide solution.

Als Vergleich wurde ein käufliches Persil© Universal Gel der Firma Henkel verwendet.As a comparison, a commercially available Persil © Universal Gel from Henkel was used.

Persil Universal Gel wurde nach Dosierungsempfehlung 40 ml/ 10L eingesetzt. Bei der Waschmittelformulierung A betrug die Gesamttensidkonzentration in der Waschflotte 0,5 g/L. Resultate der Fleckentfernung: ΔE-Wert Fleck Soja Curry Ruß Hautfett Milch/Kakao Persil© 23,98 3,7 3,97 4,57 13,11 A 24,69 3,34 3,48 3,67 11,14 Persil Universal Gel was used according to the recommended dose of 40 ml / 10L. In the detergent formulation A, the total surfactant concentration in the wash liquor was 0.5 g / L. Results of stain removal: AE value spot soy curry soot sebum Milk / cocoa Persil © 23.98 3.7 3.97 4.57 13.11 A 24.69 3.34 3.48 3.67 11.14

Eine Waschmittelformulierung enthaltend als wirksames Tensid ausschließlich eine Zusammensetzung des Beispiels 1 ist in Bezug auf die Fleckentfernung von Soja, Curry, Ruß und Hautfett genau so effektiv wie ein kommerzielles Flüssigwaschmittel auf der Basis eines optimierten Tensid-Verhältnisses von LAS, weiteren Anionentensiden und nichtionischen Tensiden.A detergent formulation containing as the effective surfactant excluding a composition of Example 1 is as effective in stain removal of soy, curry, carbon black and skin fat as a commercial liquid detergent based on an optimized surfactant ratio of LAS, other anionic surfactants and nonionic surfactants.

Beispiel 7: Vergrauungsinhibierung / Antiredeposition von Schmutz Example 7: Graying inhibition / antiredeposition of dirt

Messung der Vergrauung bzw. Antiredeposition von Schmutz:

  • Ein weiterer wichtiger Aspekt bei der Reinigung von Textilien ist, dass einmal in der Waschflotte dispergierter, gelöster oder emulgierter Schmutz sich nicht wieder auf sauberes Gewebe ablagert. Dieser unerwünschte Ablagerungseffekt ist als Vergrauung bekannt.
Measurement of graying or anti-deposition of dirt:
  • Another important aspect when cleaning textiles is that once dispersed in the wash liquor, dissolved or emulsified dirt does not re-deposit on clean tissue. This undesirable deposition effect is known as graying.

Um diesen Effekt messen zu können, wurde bei allen Waschversuchen ein sauberer weißer Baumwolllappen mitgewaschen (s.o.) und anschließend ebenfalls der ΔE-Wert von diesem gemessen. In diesem Fall liefert der reziproke ΔE-Wert ein Maß für die Vergrauung; je niedriger der reziproke ΔE-Wert desto geringer die Vergrauung. 1/ΔE-Werte Fleck Soja Curry Ruß Hautfett Milch/Kakao Persil© 0,14 0,12 0,18 0,28 0,30 A 0,15 0,10 0,15 0,35 0,22 In order to be able to measure this effect, a clean white cotton cloth was washed in all washing tests (see above) and subsequently also the ΔE value of this was measured. In this case, the reciprocal ΔE value provides a measure of graying; the lower the reciprocal ΔE value, the lower the graying. 1 / .DELTA.E values spot soy curry soot sebum Milk / cocoa Persil © 0.14 0.12 0.18 0.28 0.30 A 0.15 0.10 0.15 0.35 0.22

Es ist deutlich zu sehen, dass Rhamnolipide der spezifischen Zusammensetzung des Beispiels 1 einen geringeren Vergrauungseffekt zeigen bei Curry, Ruß, Milch/Kakao als das kommerzielle, auf LAS-Basis aufgebaute Flüssigwaschmittel und somit als Antiredepositionsmittel wirken.It can clearly be seen that rhamnolipids of the specific composition of Example 1 show a less graying effect on curry, soot, milk / cocoa than the commercial LAS-based liquid detergent and thus act as anti-redeposition agents.

Claims (14)

  1. Detergent formulation for textiles, comprising a mono- and di-rhamnolipid mixture composition, characterized in that the weight ratio of di-rhamnolipids to mono-rhamnolipids is greater than 97:3, particularly preferably greater than 98:2.
  2. Detergent formulation according to Claim 1, characterized in that the rhamnolipid mixture composition comprises
    51% by weight to 95% by weight of diRL-C10C10 and
    0.5% by weight to 9% by weight of monoRL-C10C10,
    where the percentages by weight refer to the sum of all of the rhamnolipids present.
  3. Detergent formulation according to Claim 2, characterized in that the rhamnolipid mixture composition comprises
    0.5% by weight to 15% by weight of diRL-C10C12:1,
    where the percentages by weight refer to the sum of all of the rhamnolipids present.
  4. Detergent formulation according to Claim 2 or 3, characterized in that the rhamnolipid mixture composition comprises
    0.5 to 25% by weight of diRL-C10C12,
    where the percentages by weight refer to the sum of all of the rhamnolipids present.
  5. Detergent formulation according to at least one of Claims 2 to 4, characterized in that the rhamnolipid mixture composition comprises
    0.1% by weight to 5% by weight of monoRL-C10C12 and/or, preferably and
    0.1% by weight to 5% by weight of monoRL-C10C12:1, where the percentages by weight refer to the sum of all of the rhamnolipids present.
  6. Detergent formulation according to at least one of Claims 2 to 5, characterized in that the rhamnolipid mixture composition comprises
    0.5% by weight to 15% by weight of diRL-C10C12:1,
    0.5 to 25% by weight of diRL-C10C12,
    0.1% by weight to 5% by weight of monoRL-C10C12 and
    0.1% by weight to 5% by weight of monoRL-C10C12:1,
    where the percentages by weight refer to the sum of all of the rhamnolipids present.
  7. Detergent formulation according to at least one of Claims 2 to 6, characterized in that the rhamnolipid mixture composition comprises
    0% by weight to 5% by weight of diRLC10,
    where the percentages by weight refer to the sum of all of the rhamnolipids present.
  8. Detergent formulation according to at least one of the preceding claims, characterized in that it additionally comprises at least one further surfactant.
  9. Detergent formulation according to Claim 8, characterized in that the surfactant is selected from the group comprising:
    anionic surfactants, cationic surfactants, nonionic surfactants and amphoteric surfactants, with anionic surfactants being preferred.
  10. Detergent formulation according to Claim 8 or 9, characterized in that the surfactant is selected from the group of the sulphonates and sulphates, preferably of the linear alkylbenzenesulphonates, in particular from the group of the C9-C13 alkylbenzenesulphonates, very particularly preferably sodium (n-C10-C13)-alkylbenzenesulphonate.
  11. Use of a detergent formulation according to at least one of Claims 1 to 10 for increasing the rate of foam formation and/or for foam stabilization.
  12. Use of a rhamnolipid mixture composition as named in at least one of Claims 1 to 7 for increasing the rate of foam formation and/or for foam stabilization.
  13. Use of a detergent formulation according to at least one of Claims 1 to 10 for preventing the greying of a textile and/or for use as antiredeposition agent.
  14. Use of a rhamnolipid mixture composition as named in at least one of Claims 1 to 7 for preventing the greying of a textile and/or for use as antiredeposition agent.
EP14158279.1A 2013-04-02 2014-03-07 Detergent composition for textiles comprising rhamnolipids having a predominant share of di-rhamnolipids Active EP2787065B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102013205755.5A DE102013205755A1 (en) 2013-04-02 2013-04-02 Detergent formulation for textiles containing rhamnolipids with a predominant content of di-rhamnolipids

Publications (2)

Publication Number Publication Date
EP2787065A1 EP2787065A1 (en) 2014-10-08
EP2787065B1 true EP2787065B1 (en) 2017-07-19

Family

ID=50231050

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14158279.1A Active EP2787065B1 (en) 2013-04-02 2014-03-07 Detergent composition for textiles comprising rhamnolipids having a predominant share of di-rhamnolipids

Country Status (7)

Country Link
US (1) US9243212B2 (en)
EP (1) EP2787065B1 (en)
JP (1) JP2014201745A (en)
CN (1) CN104099190B (en)
BR (1) BR102014007949B1 (en)
CA (1) CA2847909C (en)
DE (1) DE102013205755A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024115213A1 (en) * 2022-11-30 2024-06-06 Evonik Operations Gmbh Detergent compartment pouch comprising biosurfactants

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011090030A1 (en) * 2011-12-28 2013-07-04 Evonik Industries Ag Aqueous hair and skin cleansing compositions containing biosurfactants
EP2949214A1 (en) 2014-05-26 2015-12-02 Evonik Degussa GmbH Methods of producing rhamnolipids
EP3002328A1 (en) * 2014-09-30 2016-04-06 Evonik Degussa GmbH Formulation containing biotensides
EP3023431B1 (en) * 2014-11-19 2017-01-04 Evonik Degussa GmbH Concentrated, low viscosity rhamnolipid compounds
DE102014225789A1 (en) 2014-12-15 2016-06-16 Henkel Ag & Co. Kgaa Detergents and cleaners
CN113368777B (en) 2015-01-12 2022-12-30 斯泰潘公司 Preparation of rhamnolipid composition
EP3061442A1 (en) * 2015-02-27 2016-08-31 Evonik Degussa GmbH Composition comprising rhamnolipid and siloxane
EP3070155A1 (en) 2015-03-18 2016-09-21 Evonik Degussa GmbH Composition comprising peptidase and biosurfactant
CN108699097B (en) 2016-02-22 2021-11-23 赢创运营有限公司 Cosmetic use of rhamnose fatty esters as nonionic surfactant
WO2017144318A1 (en) 2016-02-22 2017-08-31 Evonik Degussa Gmbh Rhamnolipid amides for hair scent retention
WO2017157659A1 (en) 2016-03-18 2017-09-21 Evonik Degussa Gmbh Granulate comprising an inorganic solid carrier with at least one biosurfactant contained thereon
JP6955545B2 (en) 2016-07-19 2021-10-27 エボニック オペレーションズ ゲーエムベーハー Use of polyol esters to produce porous plastic coatings
WO2018065314A1 (en) 2016-10-07 2018-04-12 Evonik Degussa Gmbh Composition containing glycolipids and preservatives
EP3529259A1 (en) 2016-10-24 2019-08-28 Evonik Degussa GmbH Rhamnolipid-producing cell having reduced glucose dehydrogenase activity
PL3577126T3 (en) 2017-02-06 2023-11-27 Stepan Company Decolorization of concentrated rhamnolipid composition
US11464717B2 (en) 2017-02-10 2022-10-11 Evonik Operations Gmbh Oral care composition containing at least one biosurfactant and fluoride
EP3615646B1 (en) 2017-04-27 2024-01-24 Evonik Operations GmbH Biodegradable cleaning composition
DE102017214265A1 (en) 2017-08-16 2019-02-21 Henkel Ag & Co. Kgaa Rhamnolipid-containing detergents and cleaners
EP3749679A1 (en) 2018-02-09 2020-12-16 Evonik Operations GmbH Mixture composition comprising glucolipids
CN112105711A (en) * 2018-05-11 2020-12-18 巴斯夫欧洲公司 Detergent compositions comprising rhamnolipids and/or mannosylerythritol lipids
EP3775122A1 (en) * 2018-05-17 2021-02-17 Unilever PLC Cleaning composition comprising rhamnolipid and alkyl ether carboxylate surfactants
BR112021000774A2 (en) * 2018-07-17 2021-04-13 Unilever Ip Holdings B.V. USE OF RAMNOLIPID IN A SURFACE SYSTEM FOR MANUAL WASHING DETERGENTS
EP4117616A1 (en) * 2020-03-11 2023-01-18 Evonik Operations GmbH Mixture composition comprising glycolipids and triethyl citrate
BR112023022205A2 (en) 2021-04-29 2023-12-19 Unilever Ip Holdings B V PROCESS FOR CONVERTING DIRRAMNOLIPIDS INTO MONORHAMNOLIPIDS
CN117280041A (en) 2021-04-29 2023-12-22 联合利华知识产权控股有限公司 Method for producing monose rhamnolipid
EP4333797A1 (en) 2021-05-05 2024-03-13 Evonik Operations GmbH Compositions containing at least one biosurfactant and at least one sulfonic or sulfinic acid derivative
DE102021214680A1 (en) 2021-12-20 2023-06-22 Henkel Ag & Co. Kgaa New combination of surfactants and detergents and cleaning agents containing them
EP4234671A1 (en) 2022-02-24 2023-08-30 Evonik Operations GmbH Compositions containing biosurfactants and a lipase from stachybotrys chlorohalonata
WO2023161179A1 (en) 2022-02-24 2023-08-31 Evonik Operations Gmbh New composition containing liposomes and biosurfactants
WO2023161182A1 (en) 2022-02-24 2023-08-31 Evonik Operations Gmbh Bio based composition
WO2023198511A1 (en) 2022-04-13 2023-10-19 Evonik Operations Gmbh Process for the fermentative production of a biosurfactant
EP4269531B1 (en) 2022-04-28 2024-09-11 Evonik Operations GmbH Multifunctional wax dispersant for subterranean chemical applications
EP4269530A1 (en) 2022-04-28 2023-11-01 Evonik Operations GmbH Multifunctional wax dispersant for subterranean chemical applications
WO2024002738A1 (en) 2022-06-28 2024-01-04 Evonik Operations Gmbh Composition comprising biosurfactant and persicomycin
EP4155371A1 (en) 2022-08-29 2023-03-29 Evonik Operations GmbH Composition rich in mono-rhamnolipids
WO2024068270A1 (en) 2022-09-26 2024-04-04 Evonik Operations Gmbh Compositions comprising sophorolipids and lactic acid
DE102022210879A1 (en) 2022-10-14 2024-04-25 Henkel Ag & Co. Kgaa Surfactant mixtures
WO2024126154A1 (en) 2022-12-15 2024-06-20 Evonik Operations Gmbh Composition comprising sophorolipids and rhamnolipids and/or glucolipids
WO2024132679A1 (en) 2022-12-21 2024-06-27 Evonik Dr. Straetmans Gmbh Compositions containing biosurfactants and desferrioxamines
WO2024188924A1 (en) 2023-03-16 2024-09-19 Evonik Operations Gmbh Biosurfactants on area-measured plastic articles
CN117535104B (en) * 2023-12-21 2024-05-17 万华化学集团股份有限公司 Rhamnolipid composition for cleaning silicone oil and industrial cleaning agent

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3234258A (en) 1963-06-20 1966-02-08 Procter & Gamble Sulfation of alpha olefins
JPS58217598A (en) 1982-06-10 1983-12-17 日本油脂株式会社 Detergent composition
DE3914131A1 (en) 1989-04-28 1990-10-31 Henkel Kgaa USE OF CALCINATED HYDROTALCITES AS CATALYSTS FOR ETHOXYLATION OR PROPOXYLATION OF FATTY ACID ESTERS
US5075041A (en) 1990-06-28 1991-12-24 Shell Oil Company Process for the preparation of secondary alcohol sulfate-containing surfactant compositions
CA2060698C (en) * 1991-02-12 1997-09-30 Peter J. Hall Detergent compositions
ES2266767T3 (en) * 2003-01-28 2007-03-01 Ecover N.V. DETERGENT COMPOSITIONS.
DE102006016578A1 (en) 2006-04-06 2007-10-11 Henkel Kgaa Solid textile softening composition with a water-soluble polymer
US8592381B2 (en) * 2008-12-18 2013-11-26 Rhamnopharma Inc. Method for treating rhinitis and sinusitis by rhamnolipids
DE102009045077A1 (en) 2009-09-29 2011-03-31 Evonik Goldschmidt Gmbh Use of sophorolipids and their derivatives in combination with pesticides as adjuvant / additive for crop protection and industrial non-crop sector
DE102010014680A1 (en) 2009-11-18 2011-08-18 Evonik Degussa GmbH, 45128 Cells, nucleic acids, enzymes and their use, as well as methods for producing sophorolipids
CN102337226A (en) * 2010-07-16 2012-02-01 华东理工大学 Application of high-content dirhamnolipid of pseudomonas aeruginosa in bio-remediation
CN103052704A (en) * 2010-07-22 2013-04-17 荷兰联合利华有限公司 Combinations of rhamnolipids and enzymes for improved cleaning
EP2410039A1 (en) * 2010-07-22 2012-01-25 Unilever PLC Rhamnolipids with improved cleaning
DE102010032484A1 (en) 2010-07-28 2012-02-02 Evonik Goldschmidt Gmbh Cells and methods for producing rhamnolipids
CN103946359A (en) * 2011-09-15 2014-07-23 荷兰联合利华有限公司 Detergent compositions comprising surfactant and enzyme
US20140294925A1 (en) * 2013-03-08 2014-10-02 AGAE Technologies LLC Formulations combining ramoplanin and rhamnolipids for combating bacterial infection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024115213A1 (en) * 2022-11-30 2024-06-06 Evonik Operations Gmbh Detergent compartment pouch comprising biosurfactants

Also Published As

Publication number Publication date
JP2014201745A (en) 2014-10-27
EP2787065A1 (en) 2014-10-08
CA2847909C (en) 2021-03-02
BR102014007949A2 (en) 2015-12-08
CN104099190B (en) 2018-09-25
DE102013205755A1 (en) 2014-10-02
US9243212B2 (en) 2016-01-26
CN104099190A (en) 2014-10-15
BR102014007949A8 (en) 2021-08-31
BR102014007949B1 (en) 2022-03-03
CA2847909A1 (en) 2014-10-02
US20140296125A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
EP2787065B1 (en) Detergent composition for textiles comprising rhamnolipids having a predominant share of di-rhamnolipids
EP2786743B1 (en) Mixture composition containing rhamnolipids
EP0712436B1 (en) Low-foaming washing or cleaning agents
Geetha et al. Alkyl poly glucosides (APGs) surfactants and their properties: a review
DE4400632C1 (en) Surfactant mixtures and compositions containing these
DE69114149T2 (en) Detergent composition.
US5981450A (en) Mild detergent mixtures
WO1994006899A1 (en) Detergent mixtures
EP3250669B1 (en) Acid liquid compact washing agent containing hydroxycarboxylic acid, non-ionic surfactant and an enzyme
WO1999047635A2 (en) Aqueous multiphase detergents
EP0716680A1 (en) Use of aqueous detergent mixtures
DE19711417A1 (en) Cosmetic preparations
EP0741774B1 (en) Detergent mixtures
DE4315810A1 (en) Aqueous detergent mixtures
WO2000022084A1 (en) Hard soaps
US6013616A (en) Mild detergent mixtures
DE19859774A1 (en) Aqueous multiphase detergent
EP1656337A1 (en) Citric acid ester
DE4433070C1 (en) Mild detergent mixtures
US5952279A (en) Mild detergent mixtures
DE4300321A1 (en) Prepn. of oligo:glycerol ether sulphate from fatty alcohol oligo:glycerol ether
DE4336802A1 (en) Sulphosuccinamates
DE19641277C2 (en) Syndet soaps
DE4413435A1 (en) Compsns. for hair and body care contg. surfactant combination
DE4424823A1 (en) Strongly foaming detergent mixt. for powder and liq. washing agents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140307

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EVONIK DEGUSSA GMBH

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20170314

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 910410

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170815

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502014004619

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20170719

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171019

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171019

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171119

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171020

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 5

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502014004619

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

26N No opposition filed

Effective date: 20180420

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20180331

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180331

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180331

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180331

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 502014004619

Country of ref document: DE

Owner name: EVONIK OPERATIONS GMBH, DE

Free format text: FORMER OWNER: EVONIK DEGUSSA GMBH, 45128 ESSEN, DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20140307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170719

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 910410

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190307

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230526

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240320

Year of fee payment: 11

Ref country code: GB

Payment date: 20240320

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240328

Year of fee payment: 11